<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Antibody,Immune system,Globulins,Immune proteins,Antibody,ABO,Actin,Adaptive immune system,Affinity,Affinity maturation,Agglutination (biology)" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Antibody - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Antibody</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <div class="thumb tright">
<div class="thumbinner" style="width:257px;"><a href="../../../a/n/t/Image%7EAntibody.png_2ee7.html" class="internal" title="Each antibody binds to a specific antigen; an interaction similar to a lock and key."><img src="../../../upload/shared/5/51/Antibody.png" alt="Each antibody binds to a specific antigen; an interaction similar to a lock and key." width="255" height="360" longdesc="../../../a/n/t/Image%7EAntibody.png_2ee7.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../a/n/t/Image%7EAntibody.png_2ee7.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Each antibody binds to a specific antigen; an interaction similar to a lock and key.</div>
</div>
</div>
<p>An <b>antibody</b> or <b>immunoglobulin</b> is a large Y-shaped <a href="../../../p/r/o/Protein.html" title="Protein">protein</a> used by the <a href="../../../i/m/m/Immune_system.html" title="Immune system">immune system</a> to identify and neutralize foreign objects like <a href="../../../b/a/c/Bacterium.html" title="Bacterium">bacteria</a> and <a href="../../../v/i/r/Virus.html" title="Virus">viruses</a>. The antibody recognizes a specific target, which is called an <a href="../../../a/n/t/Antigen.html" title="Antigen">antigen</a>.<sup id="_ref-Janeway5_0" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup> An antibody contains two sites called <a href="http://en.wiktionary.org/wiki/paratope" class="extiw" title="wikt:paratope">paratopes</a> that bind antigens. These structures can be thought of as similar to locks and are specific for just one particular part of the antigen called an <a href="../../../e/p/i/Epitope.html" title="Epitope">epitope</a>, which can be thought of as similar to a key. This specific lock and key interaction allows an antibody to <i>tag</i> a <a href="../../../m/i/c/Microbe.html" title="Microbe">microbe</a> or an infected cell for attack by other parts of the immune system. The binding of an antibody can also neutralize its antigen target directly by, for example, blocking a part of a microbe that is essential for its survival and growth in the body. The production of these antibodies is the main function of the <a href="../../../h/u/m/Humoral_immune_system.html" title="Humoral immune system">humoral immune system</a>.<sup id="_ref-Pier_0" class="reference"><a href="#_note-Pier" title="">[2]</a></sup></p>
<p>More specifically, antibodies are <a href="../../../g/l/y/Glycoprotein.html" title="Glycoprotein">glycoproteins</a> belonging to the <a href="../../../i/m/m/Immunoglobulin_superfamily.html" title="Immunoglobulin superfamily">immunoglobulin superfamily</a>; the terms <i>antibody</i> and <i>immunoglobulin</i> are often used interchangeably.<sup id="_ref-Rhoades_0" class="reference"><a href="#_note-Rhoades" title="">[3]</a></sup> They can occur in two forms, a soluble form that is secreted from cells, and a <a href="../../../c/e/l/Cell_membrane.html" title="Cell membrane">membrane-bound</a> form that is attached to the surface of a <a href="../../../b/_/c/B_cell.html" title="B cell">B cell</a> and is called the B cell receptor (BCR). The BCR is only found on the surface of B cells and binding of antigen to these proteins allows the B cells to detect when the antigen is present in the body. Once the B cells bind to their antigens and are activated, they <a href="../../../c/e/l/Cellular_differentiation.html" title="Cellular differentiation">differentiate</a> into either antibody factories called <a href="../../../p/l/a/Plasma_cell.html" title="Plasma cell">plasma cells</a>, or <a href="../../../m/e/m/Memory_cell.html" title="Memory cell">memory cells</a> that will survive in the body for years afterwards, allowing the organism to remember that antigen and respond faster upon future exposures.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[4]</a></sup> In most cases, interaction of the B cell with a <a href="../../../t/_/c/T_cell.html" title="T cell">T helper cell</a> is necessary to produce full activation of the B cell and, therefore, antibody generation following antigen binding.<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[5]</a></sup> Soluble antibodies are released into the <a href="../../../b/l/o/Blood.html" title="Blood">blood</a> and tissue fluids, as well as many <a href="../../../s/e/c/Secretion.html" title="Secretion">secretions</a> to continue to survey for invading microorganisms.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Immunoglobulin_isotypes"><span class="tocnumber">1</span> <span class="toctext">Immunoglobulin isotypes</span></a></li>
<li class="toclevel-1"><a href="#Structure_of_the_antibody"><span class="tocnumber">2</span> <span class="toctext">Structure of the antibody</span></a>
<ul>
<li class="toclevel-2"><a href="#Heavy_chain"><span class="tocnumber">2.1</span> <span class="toctext">Heavy chain</span></a>
<ul>
<li class="toclevel-3"><a href="#In_mammals"><span class="tocnumber">2.1.1</span> <span class="toctext">In mammals</span></a></li>
<li class="toclevel-3"><a href="#In_fish"><span class="tocnumber">2.1.2</span> <span class="toctext">In fish</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Light_chain"><span class="tocnumber">2.2</span> <span class="toctext">Light chain</span></a></li>
<li class="toclevel-2"><a href="#Fc_region"><span class="tocnumber">2.3</span> <span class="toctext">Fc region</span></a></li>
<li class="toclevel-2"><a href="#Fab_region"><span class="tocnumber">2.4</span> <span class="toctext">Fab region</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Immunoglobulin_diversity"><span class="tocnumber">3</span> <span class="toctext">Immunoglobulin diversity</span></a>
<ul>
<li class="toclevel-2"><a href="#V.28D.29J_recombination"><span class="tocnumber">3.1</span> <span class="toctext">V(D)J recombination</span></a></li>
<li class="toclevel-2"><a href="#Somatic_hypermutation"><span class="tocnumber">3.2</span> <span class="toctext">Somatic hypermutation</span></a></li>
<li class="toclevel-2"><a href="#Class_switching"><span class="tocnumber">3.3</span> <span class="toctext">Class switching</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Affinity_versus_avidity"><span class="tocnumber">4</span> <span class="toctext">Affinity versus avidity</span></a></li>
<li class="toclevel-1"><a href="#Function"><span class="tocnumber">5</span> <span class="toctext">Function</span></a>
<ul>
<li class="toclevel-2"><a href="#Neutralization"><span class="tocnumber">5.1</span> <span class="toctext">Neutralization</span></a></li>
<li class="toclevel-2"><a href="#Agglutination"><span class="tocnumber">5.2</span> <span class="toctext">Agglutination</span></a></li>
<li class="toclevel-2"><a href="#Activation_of_complement"><span class="tocnumber">5.3</span> <span class="toctext">Activation of complement</span></a></li>
<li class="toclevel-2"><a href="#Activation_of_effector_cells"><span class="tocnumber">5.4</span> <span class="toctext">Activation of effector cells</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Medical_applications"><span class="tocnumber">6</span> <span class="toctext">Medical applications</span></a>
<ul>
<li class="toclevel-2"><a href="#RHOGAM_antibodies"><span class="tocnumber">6.1</span> <span class="toctext">RHOGAM antibodies</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Research_applications"><span class="tocnumber">7</span> <span class="toctext">Research applications</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">8</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#Additional_images"><span class="tocnumber">10</span> <span class="toctext">Additional images</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">11</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Immunoglobulin_isotypes" id="Immunoglobulin_isotypes"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Immunoglobulin isotypes">edit</a>]</span> <span class="mw-headline">Immunoglobulin isotypes</span></h2>
<p>In mammals there are five types of antibody: <a href="../../../i/g/a/IgA_3be3.html" title="IgA">IgA</a>, <a href="../../../i/g/d/IgD_248a.html" title="IgD">IgD</a>, <a href="../../../i/g/e/IgE_2615.html" title="IgE">IgE</a>, <a href="../../../i/g/g/IgG_1ca1.html" title="IgG">IgG</a>, and <a href="../../../i/g/m/IgM_159a.html" title="IgM">IgM</a>, with 4 IgG and 2 IgA subtypes present in humans (where <i>Ig</i> stands for immunoglobulin).<sup id="_ref-Janeway5_1" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup> These are classified according to differences in their heavy chain constant domains (see below for more information regarding the structural features of antibodies).<sup id="_ref-Rhoades_1" class="reference"><a href="#_note-Rhoades" title="">[3]</a></sup> Each immunoglobulin class differs in its biological properties and locations, and has evolved to deal with different antigens.<sup id="_ref-woof_0" class="reference"><a href="#_note-woof" title="">[6]</a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:202px;"><a href="../../../m/o/n/Image%7EMono-und-Polymere.svg_d8be.html" class="internal" title="Some antibodies form complexes that bind to multiple antigen molecules."><img src="../../../upload/shared/thumb/3/31/Mono-und-Polymere.svg/200px-Mono-und-Polymere.svg.png" alt="Some antibodies form complexes that bind to multiple antigen molecules." width="200" height="199" longdesc="../../../m/o/n/Image%7EMono-und-Polymere.svg_d8be.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../m/o/n/Image%7EMono-und-Polymere.svg_d8be.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Some antibodies form <a href="../../../p/r/o/Protein_structure.html" title="Protein structure">complexes</a> that bind to multiple antigen molecules.</div>
</div>
</div>
<ul>
<li>IgA can be found in areas containing mucus (e.g. in the <a href="../../../g/u/t/Gut.html" title="Gut">gut</a>, in the <a href="../../../r/e/s/Respiratory_tract.html" title="Respiratory tract">respiratory tract</a> or in the <a href="../../../u/r/o/Urogenital_tract.html" title="Urogenital tract">urogenital tract</a>) and prevents the colonization of <a href="../../../m/u/c/Mucosal.html" title="Mucosal">mucosal</a> areas by <a href="../../../p/a/t/Pathogen.html" title="Pathogen">pathogens</a>.<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[7]</a></sup></li>
<li>IgD functions mainly as an antigen receptor on B cells.<sup id="_ref-Geisberger_0" class="reference"><a href="#_note-Geisberger" title="">[8]</a></sup></li>
<li>IgE binds to <a href="../../../a/l/l/Allergens.html" title="Allergens">allergens</a> and triggers <a href="../../../h/i/s/Histamine.html" title="Histamine">histamine</a> release from <a href="../../../m/a/s/Mast_cells.html" title="Mast cells">mast cells</a> (the underlying mechanism of <a href="../../../a/l/l/Allergy.html" title="Allergy">allergy</a>) and also provides protection against pathogenic <a href="../../../w/o/r/Worm.html" title="Worm">worms</a>.<sup id="_ref-Pier_1" class="reference"><a href="#_note-Pier" title="">[2]</a></sup></li>
<li>IgG (in its four forms) provides the majority of antibody-based immunity against invading pathogens.<sup id="_ref-Pier_2" class="reference"><a href="#_note-Pier" title="">[2]</a></sup></li>
<li>IgM is expressed on the surface of B cells and also in a secreted form with very high affinity for eliminating pathogens in the early stages of B cell mediated immunity (i.e. before there is sufficient IgG to do the job).<sup id="_ref-Pier_3" class="reference"><a href="#_note-Pier" title="">[2]</a></sup><sup id="_ref-Geisberger_1" class="reference"><a href="#_note-Geisberger" title="">[8]</a></sup></li>
</ul>
<p>Immature B cells express only IgM on their cell surface (this is the surface bound form, not the secreted form of immunoglobulin). Once the naive B cell reaches maturity, it can express both IgM and IgD on its surface - it is the co-expression of both these immunoglobulin isotypes that renders the B cell 'mature' and ready to respond to antigen.<sup id="_ref-Goding_0" class="reference"><a href="#_note-Goding" title="">[9]</a></sup> Following engagement of the immunoglobulin molecule with an antigen, the B cell activates, and begins to divide and differentiate into an antibody producing cell (sometimes called a <a href="../../../p/l/a/Plasma_cell.html" title="Plasma cell">plasma cell</a>). In this activated form, the B cell produces immunoglobulin in a <a href="../../../s/e/c/Secrete.html" title="Secrete">secreted</a> form rather than a <a href="../../../c/e/l/Cell_membrane.html" title="Cell membrane">membrane</a>-bound form. Some of the <a href="../../../d/a/u/Daughter_cell.html" title="Daughter cell">daughter cells</a> of the activated B cells undergo <a href="../../../i/s/o/Isotype.html" title="Isotype">isotype</a> switching, a mechanism by which the B cell begins to express the other Ig heavy chains and thus produce the IgD, IgA or (more commonly) IgG antibody isotypes.<sup id="_ref-Neuberger_0" class="reference"><a href="#_note-Neuberger" title="">[10]</a></sup></p>
<p><a name="Structure_of_the_antibody" id="Structure_of_the_antibody"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Structure of the antibody">edit</a>]</span> <span class="mw-headline">Structure of the antibody</span></h2>
<p>Immunoglobulins are heavy <a href="../../../p/l/a/Plasma_protein.html" title="Plasma protein">plasma proteins</a>, often with sugar chains added to amino acid residues by <a href="../../../g/l/y/Glycosylation.html#N-linked_glycosylation" title="Glycosylation">N-linked glycosylation</a> (all antibodies) and occasionally <a href="../../../g/l/y/Glycosylation.html#O-linked_glycosylation" title="Glycosylation">O-linked glycosylation</a> (e.g. IgA1 and IgD).<sup id="_ref-3" class="reference"><a href="#_note-3" title="">[11]</a></sup> In other words, they are <i>glycoproteins</i>. The basic unit of each antibody is a <a href="../../../m/o/n/Monomer.html" title="Monomer">monomer</a> (one Ig unit) but the secreted antibody can also be dimeric (with two Ig units as with IgA), tetrameric (with four Ig units, like teleost fish IgM), or pentameric (with five Ig units, like mammalian IgM).<sup id="_ref-roux_0" class="reference"><a href="#_note-roux" title="">[12]</a></sup> The monomer is a "Y"-shaped molecule that consists of four <a href="../../../p/o/l/Polypeptide.html" title="Polypeptide">polypeptide</a> chains; two identical <i>heavy chains</i> and two identical <i>light chains</i> connected by <a href="../../../d/i/s/Disulfide_bond.html" title="Disulfide bond">disulfide bonds</a>.<sup id="_ref-woof_1" class="reference"><a href="#_note-woof" title="">[6]</a></sup> The tip of the Y is important for binding to antigen, while the base of the Y is important for binding to specific receptors (such as <a href="../../../f/c/_/Fc_receptor.html" title="Fc receptor">Fc receptors</a>) to allow activation immune responses appropriate for a given antigen.<sup id="_ref-4" class="reference"><a href="#_note-4" title="">[13]</a></sup></p>
<p><a name="Heavy_chain" id="Heavy_chain"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Heavy chain">edit</a>]</span> <span class="mw-headline">Heavy chain</span></h3>
<p><a name="In_mammals" id="In_mammals"></a></p>
<h4><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: In mammals">edit</a>]</span> <span class="mw-headline">In mammals</span></h4>
<p>There are five types of mammalian immunoglobulin heavy chain: γ, δ, α, μ and ε.<sup id="_ref-Janeway5_2" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup> They define <i>classes</i> of immunoglobulins. Heavy chains α and γ have approximately 450 amino acids, while μ and ε have approximately 550 amino acids.<sup id="_ref-Janeway5_3" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:302px;"><a href="../../../a/n/t/Image%7EAntibody_IgG.png_5c0d.html" class="internal" title="An antibody molecule. The two heavy chains are colored red and blue and the two light chains green and yellow. See also:[1]"><img src="../../../upload/thumb/2/2a/Antibody_IgG.png/300px-Antibody_IgG.png" alt="An antibody molecule. The two heavy chains are colored red and blue and the two light chains green and yellow. See also:[1]" width="300" height="220" longdesc="../../../a/n/t/Image%7EAntibody_IgG.png_5c0d.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../a/n/t/Image%7EAntibody_IgG.png_5c0d.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
An antibody molecule. The two heavy chains are colored red and blue and the two light chains green and yellow. See also:<a href="http://www.emc.maricopa.edu/faculty/farabee/BIOBK/ANTIBODY.gif" class="external autonumber" title="http://www.emc.maricopa.edu/faculty/farabee/BIOBK/ANTIBODY.gif" rel="nofollow">[1]</a></div>
</div>
</div>
<p>Each heavy chain has two regions:</p>
<ul>
<li>a <i>constant region</i> (which is the same for all immunoglobulins of the same class but differs between each class of immunoglobulins).
<ul>
<li>Heavy chains γ, α and δ have a constant region composed of three tandem (in a line next to each other) immunoglobulin <a href="../../../s/t/r/Structural_domain.html" title="Structural domain">domains</a> but also have a hinge region for added flexibility.<sup id="_ref-woof_2" class="reference"><a href="#_note-woof" title="">[6]</a></sup></li>
<li>Heavy chains μ and ε have a constant region composed of four immunoglobulin domains.<sup id="_ref-Janeway5_4" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup></li>
</ul>
</li>
<li>a <i>variable region</i> that differs between different B cells, but is the same for all immunoglobulins produced by the same B cell or B cell clone. The variable domain of any heavy chain is composed of a single <a href="../../../i/m/m/Immunoglobulin_fold.html" title="Immunoglobulin fold">immunoglobulin domain</a>. These domains are about 110 amino acids long.</li>
</ul>
<p><a name="In_fish" id="In_fish"></a></p>
<h4><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: In fish">edit</a>]</span> <span class="mw-headline">In fish</span></h4>
<p><a href="../../../j/a/w/Jawed_fish.html" title="Jawed fish">Jawed fish</a> appear to be the most primitive animals that are able to make antibodies like those described for mammals.<sup id="_ref-5" class="reference"><a href="#_note-5" title="">[14]</a></sup> However, fish do not have the same repertoire of antibodies that mammals possess.<sup id="_ref-6" class="reference"><a href="#_note-6" title="">[15]</a></sup> Three distinct Ig heavy chains have so far been identified in <a href="../../../b/o/n/Bony_fish.html" title="Bony fish">bony fish</a>.</p>
<ul>
<li>The first identified was the μ (or <i>mu</i>) heavy chain that is present in all jawed fish and is the heavy chain for what is thought to be the primordial immunoglobulin. The resulting antibody, IgM, is secreted as a tetramer (containing four <a href="../../../p/o/l/Polypeptide.html" title="Polypeptide">polypeptide</a> chains) in <a href="../../../t/e/l/Teleost.html" title="Teleost">teleost</a> fish instead of the typical pentamer (containing five polypeptide chains) found in mammals and sharks.</li>
</ul>
<ul>
<li>The heavy chain (δ) for IgD was identified initially from the <a href="../../../c/h/a/Channel_catfish.html" title="Channel catfish">channel catfish</a> and <a href="../../../a/t/l/Atlantic_salmon.html" title="Atlantic salmon">Atlantic salmon</a> and is now well documented for many teleost fish.<sup id="_ref-7" class="reference"><a href="#_note-7" title="">[16]</a></sup></li>
</ul>
<ul>
<li>The third teleost Ig heavy chain gene was identified very recently and does not resemble any of the heavy chains so far described for mammals. This heavy chain, identified in both <a href="../../../r/a/i/Rainbow_trout.html" title="Rainbow trout">rainbow trout</a> (τ)<sup id="_ref-8" class="reference"><a href="#_note-8" title="">[17]</a></sup> and <a href="../../../z/e/b/Zebrafish.html" title="Zebrafish">zebrafish</a> (ζ),<sup id="_ref-9" class="reference"><a href="#_note-9" title="">[18]</a></sup> could potentially form a distinct antibody <a href="../../../i/s/o/Isotype.html" title="Isotype">isotype</a> (IgT or IgZ) that may precede IgM in evolutionary terms.</li>
</ul>
<p>Similar to the situation observed for <a href="../../../b/o/n/Bony_fish.html" title="Bony fish">bony fish</a>, three distinct Ig heavy chain isotypes have been identified in <a href="../../../c/a/r/Cartilaginous_fish.html" title="Cartilaginous fish">cartilaginous fish</a>. With the exception of IgM, these Ig heavy chain isotypes appear to be unique to cartilaginous fish and are designated IgM, IgW (also called IgX or IgNARC) and IgNAR.<sup id="_ref-10" class="reference"><a href="#_note-10" title="">[19]</a></sup></p>
<p><a name="Light_chain" id="Light_chain"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Light chain">edit</a>]</span> <span class="mw-headline">Light chain</span></h3>
<p>There are only two types of light chain in mammals, λ and κ .<sup id="_ref-Janeway5_5" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup> Other types of light chains are found in lower <a href="../../../v/e/r/Vertebrate.html" title="Vertebrate">vertebrates</a> as the Ig-Light-Iota chain in <a href="../../../c/h/o/Chondrichthyes.html" title="Chondrichthyes">Chondrichthyes</a> and <a href="../../../t/e/l/Teleostei.html" title="Teleostei">Teleostei</a>.<sup id="_ref-11" class="reference"><a href="#_note-11" title="">[20]</a></sup> In each antibody, only one type is present and the two chains are identical. Each light chain has two successive domains: one constant and one variable domain. The approximate length of a light chain is from 211 to 217 amino acids.<sup id="_ref-Janeway5_6" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup></p>
<p>Camelids (see <a href="../../../c/a/m/Camel.html" title="Camel">camel</a>) are unique among all other mammals in that they have fully functional immunoglobulins which consist of two heavy chains, but lacking the light chains usually paired with each heavy chain.<sup id="_ref-12" class="reference"><a href="#_note-12" title="">[21]</a></sup> Although camels also have classical four-chain IgG1 antibodies, a <a href="../../../g/e/n/Gene_splicing.html" title="Gene splicing">splicing</a> defect in the constant IGHG2 and IGHG3 genes leads to the absence of the CH1 domain in the heavy chain.<sup id="_ref-13" class="reference"><a href="#_note-13" title="">[22]</a></sup> The functional role of this separate repertoire is unknown as yet. Apart from providing insight into immunoglobulin structure and antigen recognition in the absence of light chain CDR's, these unusual antibodies can also be exploited to generate antibody fragments even smaller than <a href="../../../s/i/n/Single_chain_variable_fragment.html" title="Single chain variable fragment">single chain variable fragments</a> (see below), but much more stable.<sup id="_ref-14" class="reference"><a href="#_note-14" title="">[23]</a></sup></p>
<div class="thumb tleft">
<div class="thumbinner" style="width:202px;"><a href="../../../2/f/a/Image%7E2fab_fc.png.html" class="internal" title="An antibody digested by papain yields two fragments, two 50 kDa Fab fragments and one 50kDa Fc fragment."><img src="../../../upload/shared/thumb/c/c9/2fab_fc.png/200px-2fab_fc.png" alt="An antibody digested by papain yields two fragments, two 50 kDa Fab fragments and one 50kDa Fc fragment." width="200" height="200" longdesc="../../../2/f/a/Image%7E2fab_fc.png.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../2/f/a/Image%7E2fab_fc.png.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
An antibody digested by <a href="../../../p/a/p/Papain.html" title="Papain">papain</a> yields two fragments, two 50 kDa Fab fragments and one 50kDa Fc fragment.</div>
</div>
</div>
<p><a name="Fc_region" id="Fc_region"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Fc region">edit</a>]</span> <span class="mw-headline">Fc region</span></h3>
<p>The <a href="../../../f/c/_/Fc_region.html" title="Fc region">Fc region</a> (<i>Fragment, crystallizable</i>), is derived from the stem of the "Y," and is composed of two heavy chains that each contribute two to three constant domains (depending on the class of the antibody).<sup id="_ref-Janeway5_7" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup> Fc binds to various cell <a href="../../../r/e/c/Receptor_%28biochemistry%29.html" title="Receptor (biochemistry)">receptors</a> and <a href="../../../c/o/m/Complement_system.html" title="Complement system">complement</a> proteins. In this way, it mediates different <a href="../../../p/h/y/Physiological.html" title="Physiological">physiological</a> effects of antibodies (<a href="../../../o/p/s/Opsonization.html" title="Opsonization">opsonization</a>, cell <a href="../../../l/y/s/Lysis.html" title="Lysis">lysis</a>, degranulation of <a href="../../../m/a/s/Mast_cells.html" title="Mast cells">mast cells</a>, <a href="../../../b/a/s/Basophils.html" title="Basophils">basophils</a> and <a href="../../../e/o/s/Eosinophils.html" title="Eosinophils">eosinophils</a> and other processes).<sup id="_ref-woof_3" class="reference"><a href="#_note-woof" title="">[6]</a></sup><sup id="_ref-15" class="reference"><a href="#_note-15" title="">[24]</a></sup></p>
<p><a name="Fab_region" id="Fab_region"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Fab region">edit</a>]</span> <span class="mw-headline">Fab region</span></h3>
<p>Each end of the forked portion of the "Y" on the antibody is called the <a href="../../../f/a/b/Fab_region.html" title="Fab region">Fab region</a> (<i>Fragment, antigen binding</i>). It is composed of one constant and one variable domain of each of the heavy and the light chain.<sup id="_ref-putnam79_0" class="reference"><a href="#_note-putnam79" title="">[25]</a></sup> These domains shape the paratope—the antigen binding site—at the <a href="../../../n/-/t/N-terminal_end.html" title="N-terminal end">amino terminal end</a> of the <a href="../../../m/o/n/Monomer.html" title="Monomer">monomer</a>. The two variable domains bind the epitope on their specific antigens.</p>
<p>In an experimental setting, Fc and Fab fragments can be generated in the laboratory. The <a href="../../../e/n/z/Enzyme.html" title="Enzyme">enzyme</a> <a href="../../../p/a/p/Papain.html" title="Papain">papain</a> can be used to cleave an immunoglobulin monomer into two <i>Fab</i> fragments and an <i>Fc</i> fragment. The enzyme <a href="../../../p/e/p/Pepsin.html" title="Pepsin">pepsin</a> cleaves below hinge region, so a F(ab')2 fragment and a Fc fragment is formed. The variable regions of the heavy and light chains can be fused together to form a <i><a href="../../../s/i/n/Single_chain_variable_fragment.html" title="Single chain variable fragment">single chain variable fragment</a> (scFv)</i>, which is only half the size of the Fab fragment yet retains the original specificity of the parent immunoglobulin.<sup id="_ref-Wu_0" class="reference"><a href="#_note-Wu" title="">[26]</a></sup></p>
<p><a name="Immunoglobulin_diversity" id="Immunoglobulin_diversity"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Immunoglobulin diversity">edit</a>]</span> <span class="mw-headline">Immunoglobulin diversity</span></h2>
<p>The success of antibodies to recognize and eradicate many different types of microbe requires their wide <a href="../../../d/i/v/Diversity.html" title="Diversity">diversity</a>; antibodies vary from one another in their amino acid composition allowing them to interact with different antigens.<sup id="_ref-16" class="reference"><a href="#_note-16" title="">[27]</a></sup> An individual vertebrate possesses a large number of different antibodies, each capable of binding to a distinct antigen or epitope from a foreign object. However, although a huge number of different antibodies are generated, there is not an equally large array of genes available, in a single individual, to make such a huge repertoire of antibodies. Vertebrate B cells have several mechanisms that allow them to generate large antibody diversity from a relatively small number of immunoglobulin genes.<sup id="_ref-namazee_0" class="reference"><a href="#_note-namazee" title="">[28]</a></sup></p>
<p><a name="V.28D.29J_recombination" id="V.28D.29J_recombination"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: V(D)J recombination">edit</a>]</span> <span class="mw-headline">V(D)J recombination</span></h3>
<p><a href="../../../s/o/m/Somatic.html" title="Somatic">Somatic</a> recombination, also known as <a href="../../../v/%28/d/V%28D%29J_recombination_744a.html" title="V(D)J recombination">V(D)J recombination</a>, of immunoglobulins involves the random selection and combination of genes encoding each segment of the immunoglobulin variable region in a manner that generates a huge repertoire of antibodies with different <a href="http://en.wiktionary.org/wiki/paratope" class="extiw" title="wikt:paratope">paratopes</a>. These segments are called variable (V), diversity (D) and joining (J) segments.<sup id="_ref-namazee_1" class="reference"><a href="#_note-namazee" title="">[28]</a></sup> V, D and J segments are found in <a href="../../../a/n/t/Antibody.html#Structure_of_the_antibody" title="Antibody">Ig heavy chains</a> but only V and J segments are found in <a href="../../../a/n/t/Antibody.html#Structure_of_the_antibody" title="Antibody">Ig light chains</a>. Multiple copies of the V, D and J segments exist tandemly arranged in the <a href="../../../g/e/n/Genome.html" title="Genome">genomes</a> of <a href="../../../m/a/m/Mammal.html" title="Mammal">mammals</a>. Their selection for recombination within the individual B cell is also called <a href="../../../g/e/n/Gene.html" title="Gene">gene</a> rearrangement.<sup id="_ref-Market_0" class="reference"><a href="#_note-Market" title="">[29]</a></sup> A B cell that successfully produces a functional immunoglobulin gene during its V(D)J recombination will suppress the expression of any other variable region <a href="../../../g/e/n/Gene.html" title="Gene">gene</a> by a process known as <a href="../../../a/l/l/Allelic_exclusion.html" title="Allelic exclusion">allelic exclusion</a>.<sup id="_ref-17" class="reference"><a href="#_note-17" title="">[30]</a></sup> Thus, the variable regions of all the immunoglobulin molecules within one given B cell will be the same, although the constant domains of the heavy chains can differ.<sup id="_ref-Janeway5_8" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup> The diversity generated by this mechanism in the variable region of the heavy chain - to be specific, in the area that these V, D and J genes encode, otherwise known as the <a href="../../../c/o/m/Complementarity_determining_region.html" title="Complementarity determining region">complementarity determining region 3</a> (CDR3) - provides the vertebrate <a href="../../../i/m/m/Immune_system.html" title="Immune system">immune system</a> its ability to bind so many distinct antigens.</p>
<p><a name="Somatic_hypermutation" id="Somatic_hypermutation"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Somatic hypermutation">edit</a>]</span> <span class="mw-headline">Somatic hypermutation</span></h3>
<p>A further mechanism for generating antibody diversity exists for the mature B cell after antigen stimulation. Activated B cells are more prone to <a href="../../../s/o/m/Somatic_hypermutation.html" title="Somatic hypermutation">somatic hypermutation</a> in their immunoglobulin variable chain genes.<sup id="_ref-18" class="reference"><a href="#_note-18" title="">[31]</a></sup> This generates slight changes in the <a href="../../../a/m/i/Amino_acid.html" title="Amino acid">amino acid</a> sequence of the variable domains of both the light and heavy chains between <a href="../../../c/l/o/Cloning.html" title="Cloning">clones</a> of the same activated B cell, and ultimately, differences in the <a href="../../../a/f/f/Affinity.html" title="Affinity">affinity</a> or strength of interaction that the B cell has with its specific antigen.<sup id="_ref-19" class="reference"><a href="#_note-19" title="">[32]</a></sup> Thus, B cells expressing immunoglobulins with higher affinity for the antigen will outcompete those with weaker immunoglobulin for function and survival in a process known as <a href="../../../a/f/f/Affinity_maturation.html" title="Affinity maturation">affinity maturation</a>.<sup id="_ref-20" class="reference"><a href="#_note-20" title="">[33]</a></sup></p>
<p><a name="Class_switching" id="Class_switching"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Class switching">edit</a>]</span> <span class="mw-headline">Class switching</span></h3>
<p><a href="../../../i/m/m/Immunoglobulin_class_switching.html" title="Immunoglobulin class switching">Isotype switching</a> (or class switching) occurs after the process of V(D)J recombination and following activation of the mature B cell (see above) to generate the different classes of antibody, all with the same variable domains as the original immunoglobulin generated in the immature B cell during recombination, but possessing distinct constant domains in their <a href="../../../a/n/t/Antibody.html#Structure_of_the_antibody" title="Antibody">heavy chains</a>.<sup id="_ref-Market_1" class="reference"><a href="#_note-Market" title="">[29]</a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="../../../i/g/m/Image%7EIgM.png_8f9e.html" class="internal" title="The secreted mammalian IgM molecule, with its five Ig units."><img src="../../../upload/shared/thumb/f/f3/IgM.png/180px-IgM.png" alt="The secreted mammalian IgM molecule, with its five Ig units." width="180" height="170" longdesc="../../../i/g/m/Image%7EIgM.png_8f9e.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../i/g/m/Image%7EIgM.png_8f9e.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
The secreted mammalian IgM molecule, with its five Ig units.</div>
</div>
</div>
<p><a name="Affinity_versus_avidity" id="Affinity_versus_avidity"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Affinity versus avidity">edit</a>]</span> <span class="mw-headline">Affinity versus avidity</span></h2>
<p>Depending on the structure of the antibody (which varies with the isotype) and that of the antigen, an antibody may have only one binding interaction with the antigen (monovalent) or multiple simultaneous interactions (multivalent).<sup id="_ref-Janeway5_9" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup></p>
<ul>
<li><a href="../../../a/f/f/Affinity.html" title="Affinity">Affinity</a> is the binding strength of a single antibody - antigen interaction.</li>
<li><a href="../../../a/v/i/Avidity.html" title="Avidity">Avidity</a> is the compound affinity of multiple antibody - antigen interactions when more than one takes place between the two molecules. That is, avidity is the apparent affinity of the antigen - antibody binding in these cases, not the true affinity.</li>
</ul>
<p>Avidity can be orders of magnitude greater than affinity, helping for instance poorly affinity-matured but highly multivalent IgM still bind antigen efficiently.<sup id="_ref-21" class="reference"><a href="#_note-21" title="">[34]</a></sup></p>
<p><a name="Function" id="Function"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Function">edit</a>]</span> <span class="mw-headline">Function</span></h2>
<dl>
<dd><i>Further information: <a href="../../../i/m/m/Immune_system.html" title="Immune system">Immune system</a></i></dd>
</dl>
<p>Since antibodies exist freely in the bloodstream or bound to cell membranes, they are said to be part of the <a href="../../../h/u/m/Humoral_immune_system.html" title="Humoral immune system">humoral immune system</a>. The circulating antibodies are produced by clonal B cells that are specific to only one <a href="../../../a/n/t/Antigen.html" title="Antigen">antigen</a> (e.g., a virus hull protein fragment). In binding their specific antigens, the antibodies can cause agglutination and <a href="../../../p/r/e/Precipitation_%28chemistry%29.html" title="Precipitation (chemistry)">precipitation</a> of antibody-antigen products primed for <a href="../../../p/h/a/Phagocytosis.html" title="Phagocytosis">phagocytosis</a> by <a href="../../../m/a/c/Macrophages.html" title="Macrophages">macrophages</a> and other cells, <a href="../../../a/n/t/Antagonism.html" title="Antagonism">block</a> viral receptors, and stimulate other <a href="../../../i/m/m/Immune_response.html" title="Immune response">immune responses</a>, such as the <a href="../../../c/o/m/Complement_system.html" title="Complement system">complement pathway</a>.<sup id="_ref-Ravetch_0" class="reference"><a href="#_note-Ravetch" title="">[35]</a></sup></p>
<p><a name="Neutralization" id="Neutralization"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Neutralization">edit</a>]</span> <span class="mw-headline">Neutralization</span></h3>
<p>Antibodies that recognize <a href="../../../v/i/r/Virus.html" title="Virus">viruses</a> can block these by binding them directly.<sup id="_ref-Pier_4" class="reference"><a href="#_note-Pier" title="">[2]</a></sup> In doing so, the virus will be unable to dock to its preferred receptor on a host cell in order to infect it. Some antibodies, like IgA, also directly bind to microbes in <a href="../../../m/u/c/Mucus.html" title="Mucus">mucus</a> to prevent the colonization of <a href="../../../m/u/c/Mucosal_tissue.html" title="Mucosal tissue">mucosal tissues</a>. Some antibodies, like those in <a href="../../../a/n/t/Antivenin.html" title="Antivenin">antivenoms</a>, neutralize <a href="../../../t/o/x/Toxin.html" title="Toxin">toxins</a> by binding to them.<sup id="_ref-22" class="reference"><a href="#_note-22" title="">[36]</a></sup> Problems can occur with certain viruses if antibody neutralization is inadequate. For example, when certain viruses such as the <a href="../../../h/i/v/HIV_abc5.html" title="HIV">HIV</a>, are not completely covered by neurtralizing antibody, the antibodies can enhance viral infectivity instead of inhibiting it; HIV prefers to infect the cells that bind to antibodies.<sup id="_ref-Weiss1_0" class="reference"><a href="#_note-Weiss1" title="">[37]</a></sup> Antibodies cannot attack pathogens within cells, and certain viruses (such as HIV, <a href="../../../h/e/r/Herpes_simplex_virus.html" title="Herpes simplex virus">HSV</a> and <a href="../../../h/b/v/HBV_0373.html" title="HBV">HBV</a>) "hide" inside cells for long periods of time to avoid them.<sup id="_ref-Pier_5" class="reference"><a href="#_note-Pier" title="">[2]</a></sup> This is the reason for the <a href="../../../c/h/r/Chronic_%28medicine%29.html" title="Chronic (medicine)">chronic</a> nature of many minor skin diseases (such as <a href="../../../c/o/l/Cold_sores.html" title="Cold sores">cold sores</a>); any given outbreak is quickly suppressed by the immune system, but the infection is never truly <a href="../../../e/r/a/Eradicate.html" title="Eradicate">eradicated</a> because some cells retain viruses that will resume the symptoms later.<sup id="_ref-Pier_6" class="reference"><a href="#_note-Pier" title="">[2]</a></sup></p>
<p><a name="Agglutination" id="Agglutination"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Agglutination">edit</a>]</span> <span class="mw-headline">Agglutination</span></h3>
<p>Antibodies are clonally generated for binding single specific antigens, which may compose specific molecules on the surfaces of viruses or <a href="../../../c/e/l/Cell_%28biology%29.html" title="Cell (biology)">cells</a>. The antibodies can link these viruses or cells together, causing them to <a href="../../../a/g/g/Agglutination_%28biology%29.html" title="Agglutination (biology)">agglutinate</a> (coagulate) so <a href="../../../p/h/a/Phagocytes.html" title="Phagocytes">phagocytes</a> can capture them.<sup id="_ref-Pier_7" class="reference"><a href="#_note-Pier" title="">[2]</a></sup></p>
<div class="thumb tleft">
<div class="thumbinner" style="width:202px;"><a href="../../../f/c/_/Image%7EFc_receptor_schematic_big.png_a8c9.html" class="internal" title="Schematic diagram showing Fc receptor interaction with an antibody-coated microbial pathogen."><img src="../../../upload/thumb/2/25/Fc_receptor_schematic_big.png/200px-Fc_receptor_schematic_big.png" alt="Schematic diagram showing Fc receptor interaction with an antibody-coated microbial pathogen." width="200" height="200" longdesc="../../../f/c/_/Image%7EFc_receptor_schematic_big.png_a8c9.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../f/c/_/Image%7EFc_receptor_schematic_big.png_a8c9.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Schematic diagram showing Fc receptor interaction with an antibody-coated microbial pathogen.</div>
</div>
</div>
<p><a name="Activation_of_complement" id="Activation_of_complement"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Activation of complement">edit</a>]</span> <span class="mw-headline">Activation of complement</span></h3>
<p>Antibodies that bind to surface antigens on, for example a bacterium, will bind the first component of the complement system with their <a href="../../../a/n/t/Antibody.html#Fc_region" title="Antibody">Fc region</a> and initiate activation of the "classical" complement system.<sup id="_ref-Ravetch_1" class="reference"><a href="#_note-Ravetch" title="">[35]</a></sup> This results in the killing of bacteria in two ways.<sup id="_ref-Pier_8" class="reference"><a href="#_note-Pier" title="">[2]</a></sup> First, the binding of the antibody and complement molecules marks the microbe for ingestion by phagocytes in a process called <a href="../../../o/p/s/Opsonization.html" title="Opsonization">opsonization</a>. These phagocytes are attracted by some of the complement molecules that are generated in the complement cascade. Secondly, some complement system components form a <i><a href="../../../c/o/m/Complement_membrane_attack_complex.html" title="Complement membrane attack complex">membrane attack complex</a></i> to assist the antibodies to kill bacteria directly.<sup id="_ref-23" class="reference"><a href="#_note-23" title="">[38]</a></sup></p>
<p><a name="Activation_of_effector_cells" id="Activation_of_effector_cells"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Activation of effector cells">edit</a>]</span> <span class="mw-headline">Activation of effector cells</span></h3>
<p>Some cells (e.g. <a href="../../../m/a/s/Mast_cells.html" title="Mast cells">Mast cells</a> and phagocytes) have specific receptors on their cell surface for binding antibodies. These are called <a href="../../../f/c/_/Fc_receptor.html" title="Fc receptor">Fc receptors</a>, and, as the name suggests, these receptors interact with the <a href="../../../f/c/_/Fc_region.html" title="Fc region">Fc region</a> of some antibodies (e.g. IgA, IgG, IgE). The engagement of a particular antibody with the Fc receptor on a particular cell will trigger the effector function of that cell (e.g. phagocytes will phagocytose, mast cells will degranulate) that will ultimately result in destruction of the invading microbe. The Fc receptors are isotype-specific, which gives a great flexibility to the immune system, because different situations require only certain immune mechanisms to respond to antigens.<sup id="_ref-Janeway5_10" class="reference"><a href="#_note-Janeway5" title="">[1]</a></sup></p>
<p><a name="Medical_applications" id="Medical_applications"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Medical applications">edit</a>]</span> <span class="mw-headline">Medical applications</span></h2>
<p>Detection of particular antibodies is a very common form of medical diagnostics. <a href="../../../s/e/r/Serology.html" title="Serology">Serology</a> depends on these methods.<sup id="_ref-24" class="reference"><a href="#_note-24" title="">[39]</a></sup> <a href="../../../a/u/t/Autoimmune_disorder.html" title="Autoimmune disorder">Autoimmune disorders</a> can often be traced to antibodies that bind the body's own <a href="../../../e/p/i/Epitope.html" title="Epitope">epitopes</a>; many can be detected through <a href="../../../b/l/o/Blood_test.html" title="Blood test">blood tests</a>. Antibodies directed against <a href="../../../r/e/d/Red_blood_cell.html" title="Red blood cell">RBC</a> surface antigens in immune mediated <a href="../../../h/e/m/Hemolytic_anemia.html" title="Hemolytic anemia">hemolytic anemia</a> can be detected with the <a href="../../../c/o/o/Coombs_test.html" title="Coombs test">Coombs test</a>.<sup id="_ref-Dean_0" class="reference"><a href="#_note-Dean" title="">[40]</a></sup> The Coombs test is also used for antibody screening in blood transfusion preparation and also for antibody screening in antenatal women.<sup id="_ref-Dean_1" class="reference"><a href="#_note-Dean" title="">[40]</a></sup></p>
<p>"Targeted" <a href="../../../m/o/n/Monoclonal_antibody.html" title="Monoclonal antibody">monoclonal antibody</a> therapy is already being employed to treat diseases such as <a href="../../../r/h/e/Rheumatoid_arthritis.html" title="Rheumatoid arthritis">rheumatoid arthritis</a>,<sup id="_ref-25" class="reference"><a href="#_note-25" title="">[41]</a></sup> multiple sclerosis,<sup id="_ref-26" class="reference"><a href="#_note-26" title="">[42]</a></sup> psoriasis,<sup id="_ref-27" class="reference"><a href="#_note-27" title="">[43]</a></sup> and in many forms of <a href="../../../c/a/n/Cancer.html" title="Cancer">cancer</a> including non-Hodgkin's lymphoma,<sup id="_ref-28" class="reference"><a href="#_note-28" title="">[44]</a></sup> colorectal cancer, head and neck cancer and breast cancer.<sup id="_ref-29" class="reference"><a href="#_note-29" title="">[45]</a></sup></p>
<p>Some immune deficiencies, such as <a href="../../../x/-/l/X-linked_agammaglobulinemia.html" title="X-linked agammaglobulinemia">X-linked agammaglobulinemia</a> and <a href="../../../h/y/p/Hypogammaglobulinemia.html" title="Hypogammaglobulinemia">hypogammaglobulinemia</a> result in partial or complete lack of antibodies.<sup id="_ref-30" class="reference"><a href="#_note-30" title="">[46]</a></sup> These diseases are often treated by inducing a short term form of <a href="../../../i/m/m/Immunity_%28medical%29.html" title="Immunity (medical)">immunity</a> called <a href="../../../p/a/s/Passive_immunity.html" title="Passive immunity">passive immunity</a>. Passive immunity is achieved through the transfer of ready made antibodies in the form of human or animal serum, pooled immunoglobulin or monoclonal antibodies, into the affected individual.<sup id="_ref-USC_0" class="reference"><a href="#_note-USC" title="">[47]</a></sup></p>
<p>Elevations in the different classes of immunoglobulins are sometimes useful in determining the cause of <a href="../../../l/i/v/Liver.html" title="Liver">liver</a> damage in patients whom the diagnosis is unclear.<sup id="_ref-Rhoades_2" class="reference"><a href="#_note-Rhoades" title="">[3]</a></sup> For example, elevated IgA indicates alcoholic <a href="../../../c/i/r/Cirrhosis.html" title="Cirrhosis">cirrhosis</a>, elevated IgM indicates <a href="../../../h/e/p/Hepatitis.html#viral_hepatitis" title="Hepatitis">viral hepatitis</a> and <a href="../../../p/r/i/Primary_biliary_cirrhosis.html" title="Primary biliary cirrhosis">primary biliary cirrhosis</a>, while IgG is elevated in <a href="../../../h/e/p/Hepatitis.html#viral_hepatitis" title="Hepatitis">viral hepatitis</a>, <a href="../../../a/u/t/Autoimmune_hepatitis.html" title="Autoimmune hepatitis">autoimmune hepatitis</a> and cirrhosis.</p>
<p><a name="RHOGAM_antibodies" id="RHOGAM_antibodies"></a></p>
<h4><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: RHOGAM antibodies">edit</a>]</span> <span class="mw-headline">RHOGAM antibodies</span></h4>
<p>RHOGAM antibodies are a trade name for <a href="../../../r/h/o/Rho%28D%29_Immune_Globulin_5c69.html" title="Rho(D) Immune Globulin">Rho(D) Immune Globulin</a> antibodies specific to the human Rh D antigen.<sup id="_ref-31" class="reference"><a href="#_note-31" title="">[48]</a></sup> They normally administered as part of a pre-natal treatment regimen to prevent any sensitization that may occur when a Rhesus-negative mother has a <a href="../../../f/e/t/Fetus.html" title="Fetus">fetus</a> that is Rhesus-positive. The <a href="../../../r/h/e/Rhesus_factor.html" title="Rhesus factor">Rhesus factor</a> (a.k.a. D antigen) is an <a href="../../../a/n/t/Antigen.html" title="Antigen">antigen</a> found on red blood cells in the blood. It is the second most significant risk issue in a blood transfusion, next to the <a href="../../../a/b/o/ABO_dd88.html" title="ABO">ABO</a> <a href="../../../b/l/o/Blood_type.html" title="Blood type">blood type</a>. People that are Rh+ have this antigen on their red blood cells. People that are Rh- don't have this antigen on their red blood cells.</p>
<p>In the course of regular childbirth delivery trauma or other prenatal complications, blood from the fetus occasionally enters the mother's system. In the case of an Rh-incompatible mother and child, blood mixing from this trauma may 'sensitize' the Rh-negative mother to the Rh antigen, putting the remainder of the pregnancy, and any subsequent pregnancies, at risk for <a href="../../../h/e/m/Hemolytic_disease_of_the_newborn.html" title="Hemolytic disease of the newborn">hemolytic disease of the newborn</a>.<sup id="_ref-32" class="reference"><a href="#_note-32" title="">[49]</a></sup></p>
<p>In contrast, treatment of an unsensitized mother with RhoGAM antibodies prior to and immediately after trauma and delivery will immediately destroy any Rh antigen incidentally in the mother's system from the fetus. Importantly, this will happen before the antigen can stimulate the mother's memory-mediated immune response B cells to "remember" Rh antigen. Therefore, her <a href="../../../h/u/m/Humoral_immune_system.html" title="Humoral immune system">humoral immune system</a> will never be stimulated to make anti-Rh antibodies, and will not attack the current, or any potential subsequent, baby's Rhesus antigens. RhoGAM prevents 'sensitization' that can lead to Rh disease, but does not prevent or treat the underlying disease itself.</p>
<p><a name="Research_applications" id="Research_applications"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Research applications">edit</a>]</span> <span class="mw-headline">Research applications</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:302px;"><a href="../../../f/l/u/Image%7EFluorescentCells.jpg_71af.html" class="internal" title="Immunofluorescence image of the eukaryotic cytoskeleton. Actin filaments are shown in red, microtubules in green, and the nuclei in blue."><img src="../../../upload/shared/thumb/0/09/FluorescentCells.jpg/300px-FluorescentCells.jpg" alt="Immunofluorescence image of the eukaryotic cytoskeleton. Actin filaments are shown in red, microtubules in green, and the nuclei in blue." width="300" height="300" longdesc="../../../f/l/u/Image%7EFluorescentCells.jpg_71af.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../f/l/u/Image%7EFluorescentCells.jpg_71af.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="../../../i/m/m/Immunofluorescence.html" title="Immunofluorescence">Immunofluorescence</a> image of the eukaryotic <a href="../../../c/y/t/Cytoskeleton.html" title="Cytoskeleton">cytoskeleton</a>. <a href="../../../a/c/t/Actin.html" title="Actin">Actin</a> filaments are shown in red, <a href="../../../m/i/c/Microtubule.html" title="Microtubule">microtubules</a> in green, and the <a href="../../../c/e/l/Cell_nucleus.html" title="Cell nucleus">nuclei in blue</a>.</div>
</div>
</div>
<p>In research, antibodies are used in many applications. The most common is the identification and localization of <a href="../../../i/n/t/Intracellular.html" title="Intracellular">intracellular</a> and <a href="../../../e/x/t/Extracellular.html" title="Extracellular">extracellular</a> proteins. Antibodies may be used to differentiate cell types (see <a href="../../../f/l/o/Flow_cytometry.html" title="Flow cytometry">flow cytometry</a>),<sup id="_ref-Stecher_0" class="reference"><a href="#_note-Stecher" title="">[50]</a></sup> to separate proteins (and anything bound to them) from the other molecules in a cell lysate (See <a href="../../../i/m/m/Immunoprecipitation.html" title="Immunoprecipitation">immunoprecipitation</a>),<sup id="_ref-33" class="reference"><a href="#_note-33" title="">[51]</a></sup> to identify proteins after <a href="../../../e/l/e/Electrophoresis.html" title="Electrophoresis">electrophoresis</a> (See <a href="../../../w/e/s/Western_blot.html" title="Western blot">Western blot</a>),<sup id="_ref-34" class="reference"><a href="#_note-34" title="">[52]</a></sup> or to examine protein expression in tissues (See <a href="../../../i/m/m/Immunohistochemical_staining.html" title="Immunohistochemical staining">immunohistochemical staining</a>,<sup id="_ref-35" class="reference"><a href="#_note-35" title="">[53]</a></sup> and examine the localisation of proteins within cells <a href="../../../i/m/m/Immunofluorescence.html" title="Immunofluorescence">immunofluorescence</a>).<sup id="_ref-Stecher_1" class="reference"><a href="#_note-Stecher" title="">[50]</a></sup></p>
<p>These purified antibodies are often produced by injecting the antigen into a small <a href="../../../m/a/m/Mammal.html" title="Mammal">mammal</a>, such as a <a href="../../../m/o/u/Mouse.html" title="Mouse">mouse</a> or <a href="../../../r/a/b/Rabbit.html" title="Rabbit">rabbit</a>. Sometimes, in order to obtain large quantity of antibodies, goats, sheep, or horses are used. Blood isolated from these animals contains <i><a href="../../../p/o/l/Polyclonal_antibody.html" title="Polyclonal antibody">polyclonal antibodies</a></i> -- multiple antibodies that bind to the same antigen. The <a href="../../../b/l/o/Blood_plasma.html" title="Blood plasma">serum</a>, also known as the <a href="../../../a/n/t/Antiserum.html" title="Antiserum">antiserum</a>, because it now contains the desired antibodies, is commonly purified with Protein A/G purification or antigen affinity <a href="../../../c/h/r/Chromatography.html" title="Chromatography">chromatography</a>.<sup id="_ref-36" class="reference"><a href="#_note-36" title="">[54]</a></sup> If the lymphocytes that produce the antibodies can be isolated and <a href="../../../b/i/o/Biological_immortality.html" title="Biological immortality">immortalized</a>, then a <i><a href="../../../m/o/n/Monoclonal_antibodies.html" title="Monoclonal antibodies">monoclonal antibody</a></i> can be obtained.</p>
<p>In biochemical assays for disease diagnosis,<sup id="_ref-37" class="reference"><a href="#_note-37" title="">[55]</a></sup> a titer of <a href="../../../e/p/s/Epstein-Barr_virus_6f15.html" title="Epstein-Barr virus">Epstein-Barr virus</a> or <a href="../../../l/y/m/Lyme_disease.html" title="Lyme disease">Lyme disease</a> will look for antibodies produced by the body that are specific to those antigens in the blood. If those antibodies are not present, either the person has not been infected, or the infection occurred a <i>very</i> long time ago, and the antibodies have naturally decayed.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../i/m/m/Immunology.html" title="Immunology">Immunology</a></li>
<li><a href="../../../i/m/m/Immunosuppressive_drug.html" title="Immunosuppressive drug">Immunosuppressive drug</a></li>
<li><a href="../../../m/o/n/Monoclonal_antibody.html" title="Monoclonal antibody">Monoclonal antibody</a></li>
<li><a href="../../../a/n/t/Anti-mitochondrial_antibodies.html" title="Anti-mitochondrial antibodies">Anti-mitochondrial antibodies</a></li>
<li><a href="../../../h/u/m/Humoral_immunity.html" title="Humoral immunity">Humoral immunity</a></li>
<li><a href="../../../n/a/n/Nanobodies.html" title="Nanobodies">Nanobodies</a></li>
<li><a href="../../../s/e/c/Secondary_antibodies.html" title="Secondary antibodies">Secondary antibodies</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small" style="-moz-column-count:2; column-count:2};">
<ol class="references">
<li id="_note-Janeway5">^ <a href="#_ref-Janeway5_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Janeway5_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-Janeway5_2" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-Janeway5_3" title=""><sup><i><b>d</b></i></sup></a> <a href="#_ref-Janeway5_4" title=""><sup><i><b>e</b></i></sup></a> <a href="#_ref-Janeway5_5" title=""><sup><i><b>f</b></i></sup></a> <a href="#_ref-Janeway5_6" title=""><sup><i><b>g</b></i></sup></a> <a href="#_ref-Janeway5_7" title=""><sup><i><b>h</b></i></sup></a> <a href="#_ref-Janeway5_8" title=""><sup><i><b>i</b></i></sup></a> <a href="#_ref-Janeway5_9" title=""><sup><i><b>j</b></i></sup></a> <a href="#_ref-Janeway5_10" title=""><sup><i><b>k</b></i></sup></a> <cite class="book" style="font-style:normal"><a href="../../../c/h/a/Charles_Janeway_90e6.html" title="Charles Janeway">Janeway CA, Jr.</a> <i>et al</i> (2001). <i>Immunobiology.</i>, 5th ed., Garland Publishing. <a href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowTOC&amp;rid=imm.TOC&amp;depth=10" class="external text" title="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowTOC&amp;rid=imm.TOC&amp;depth=10" rel="nofollow">(electronic full text via NCBI Bookshelf)</a> <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-8153-3642-X</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Immunobiology.&amp;rft.title=Immunobiology.&amp;rft.au=%5B%5BCharles+Janeway%7CJaneway+CA%2C+Jr.%5D%5D+%27%27et+al%27%27&amp;rft.date=2001&amp;rft.edition=5th+ed.&amp;rft.pub=Garland+Publishing">&#160;</span></li>
<li id="_note-Pier">^ <a href="#_ref-Pier_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Pier_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-Pier_2" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-Pier_3" title=""><sup><i><b>d</b></i></sup></a> <a href="#_ref-Pier_4" title=""><sup><i><b>e</b></i></sup></a> <a href="#_ref-Pier_5" title=""><sup><i><b>f</b></i></sup></a> <a href="#_ref-Pier_6" title=""><sup><i><b>g</b></i></sup></a> <a href="#_ref-Pier_7" title=""><sup><i><b>h</b></i></sup></a> <a href="#_ref-Pier_8" title=""><sup><i><b>i</b></i></sup></a> <cite class="book" style="font-style:normal">Pier GB, Lyczak JB, Wetzler LM (2004). <i>Immunology, Infection, and Immunity</i>. ASM Press. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 1-55581-246-5</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Immunology%2C+Infection%2C+and+Immunity&amp;rft.title=Immunology%2C+Infection%2C+and+Immunity&amp;rft.au=Pier+GB%2C+Lyczak+JB%2C+Wetzler+LM&amp;rft.date=2004&amp;rft.pub=ASM+Press">&#160;</span></li>
<li id="_note-Rhoades">^ <a href="#_ref-Rhoades_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Rhoades_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-Rhoades_2" title=""><sup><i><b>c</b></i></sup></a> <cite class="book" style="font-style:normal">Rhoades RA, Pflanzer RG (2002). <i>Human Physiology</i>, 4th ed., Thomson Learning. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-534-42174-1</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Human+Physiology&amp;rft.title=Human+Physiology&amp;rft.au=Rhoades+RA%2C+Pflanzer+RG&amp;rft.date=2002&amp;rft.edition=4th+ed.&amp;rft.pub=Thomson+Learning">&#160;</span></li>
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <cite style="font-style:normal">Borghesi L, Milcarek C (2006). "From B cell to plasma cell: regulation of V(D)J recombination and antibody secretion". <i>Immunol Res</i> <b>36</b> (1-3): 27-32. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17337763" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17337763">PMID 17337763</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=From+B+cell+to+plasma+cell%3A+regulation+of+V%28D%29J+recombination+and+antibody+secretion&amp;rft.title=Immunol+Res&amp;rft.jtitle=Immunol+Res&amp;rft.date=2006&amp;rft.volume=36&amp;rft.issue=1-3&amp;rft.au=Borghesi+L%2C+Milcarek+C&amp;rft.pages=27-32&amp;rft_id=info:pmid/17337763">&#160;</span></li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <cite style="font-style:normal">Parker D (1993). "T cell-dependent B cell activation". <i>Annu Rev Immunol</i> <b>11</b>: 331-60. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8476565" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8476565">PMID 8476565</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=T+cell-dependent+B+cell+activation&amp;rft.title=Annu+Rev+Immunol&amp;rft.jtitle=Annu+Rev+Immunol&amp;rft.date=1993&amp;rft.volume=11&amp;rft.au=Parker+D&amp;rft.pages=331-60&amp;rft_id=info:pmid/8476565">&#160;</span></li>
<li id="_note-woof">^ <a href="#_ref-woof_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-woof_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-woof_2" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-woof_3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal">Woof J, Burton D (2004). "Human antibody-Fc receptor interactions illuminated by crystal structures". <i>Nat Rev Immunol</i> <b>4</b> (2): 89-99. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15040582" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15040582">PMID 15040582</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Human+antibody-Fc+receptor+interactions+illuminated+by+crystal+structures&amp;rft.title=Nat+Rev+Immunol&amp;rft.jtitle=Nat+Rev+Immunol&amp;rft.date=2004&amp;rft.volume=4&amp;rft.issue=2&amp;rft.au=Woof+J%2C+Burton+D&amp;rft.pages=89-99&amp;rft_id=info:pmid/15040582">&#160;</span></li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> <cite style="font-style:normal">Underdown B, Schiff J (1986). "Immunoglobulin A: strategic defense initiative at the mucosal surface". <i>Annu Rev Immunol</i> <b>4</b>: 389-417. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3518747" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3518747">PMID 3518747</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Immunoglobulin+A%3A+strategic+defense+initiative+at+the+mucosal+surface&amp;rft.title=Annu+Rev+Immunol&amp;rft.jtitle=Annu+Rev+Immunol&amp;rft.date=1986&amp;rft.volume=4&amp;rft.au=Underdown+B%2C+Schiff+J&amp;rft.pages=389-417&amp;rft_id=info:pmid/3518747">&#160;</span></li>
<li id="_note-Geisberger">^ <a href="#_ref-Geisberger_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Geisberger_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Geisberger R, Lamers M, Achatz G (2006). "The riddle of the dual expression of IgM and IgD". <i>Immunology</i> <b>118</b> (4): 429-37. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16895553" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16895553">PMID 16895553</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+riddle+of+the+dual+expression+of+IgM+and+IgD&amp;rft.title=Immunology&amp;rft.jtitle=Immunology&amp;rft.date=2006&amp;rft.volume=118&amp;rft.issue=4&amp;rft.au=Geisberger+R%2C+Lamers+M%2C+Achatz+G&amp;rft.pages=429-37&amp;rft_id=info:pmid/16895553">&#160;</span></li>
<li id="_note-Goding"><b><a href="#_ref-Goding_0" title="">^</a></b> <cite style="font-style:normal">Goding J. "Allotypes of IgM and IgD receptors in the mouse: a probe for lymphocyte differentiation". <i>Contemp Top Immunobiol</i> <b>8</b>: 203-43. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=357078" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=357078">PMID 357078</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Allotypes+of+IgM+and+IgD+receptors+in+the+mouse%3A+a+probe+for+lymphocyte+differentiation&amp;rft.title=Contemp+Top+Immunobiol&amp;rft.jtitle=Contemp+Top+Immunobiol&amp;rft.volume=8&amp;rft.au=Goding+J&amp;rft.pages=203-43&amp;rft_id=info:pmid/357078">&#160;</span></li>
<li id="_note-Neuberger"><b><a href="#_ref-Neuberger_0" title="">^</a></b> <cite style="font-style:normal">Neuberger M, Ehrenstein M, Rada C, Sale J, Batista F, Williams G, Milstein C (2000). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=10794054" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=10794054" rel="nofollow">Memory in the B-cell compartment: antibody affinity maturation</a>". <i>Philos Trans R Soc Lond B Biol Sci</i> <b>355</b> (1395): 357-60. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10794054" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10794054">PMID 10794054</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Memory+in+the+B-cell+compartment%3A+antibody+affinity+maturation&amp;rft.title=Philos+Trans+R+Soc+Lond+B+Biol+Sci&amp;rft.jtitle=Philos+Trans+R+Soc+Lond+B+Biol+Sci&amp;rft.date=2000&amp;rft.volume=355&amp;rft.issue=1395&amp;rft.au=Neuberger+M%2C+Ehrenstein+M%2C+Rada+C%2C+Sale+J%2C+Batista+F%2C+Williams+G%2C+Milstein+C&amp;rft.pages=357-60&amp;rft_id=info:pmid/10794054&amp;rft_id=http%3A%2F%2Fwww.pubmedcentral.nih.gov%2Farticlerender.fcgi%3Ftool%3Dpubmed%26pubmedid%3D10794054">&#160;</span></li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> <cite style="font-style:normal">Mattu T, Pleass R, Willis A, Kilian M, Wormald M, Lellouch A, Rudd P, Woof J, Dwek R (1998). "The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions". <i>J Biol Chem</i> <b>273</b> (4): 2260-72. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9442070" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9442070">PMID 9442070</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+glycosylation+and+structure+of+human+serum+IgA1%2C+Fab%2C+and+Fc+regions+and+the+role+of+N-glycosylation+on+Fc+alpha+receptor+interactions&amp;rft.title=J+Biol+Chem&amp;rft.jtitle=J+Biol+Chem&amp;rft.date=1998&amp;rft.volume=273&amp;rft.issue=4&amp;rft.au=Mattu+T%2C+Pleass+R%2C+Willis+A%2C+Kilian+M%2C+Wormald+M%2C+Lellouch+A%2C+Rudd+P%2C+Woof+J%2C+Dwek+R&amp;rft.pages=2260-72&amp;rft_id=info:pmid/9442070">&#160;</span></li>
<li id="_note-roux"><b><a href="#_ref-roux_0" title="">^</a></b> <cite style="font-style:normal">Roux K (1999). "Immunoglobulin structure and function as revealed by electron microscopy". <i>Int Arch Allergy Immunol</i> <b>120</b> (2): 85-99. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10545762" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10545762">PMID 10545762</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Immunoglobulin+structure+and+function+as+revealed+by+electron+microscopy&amp;rft.title=Int+Arch+Allergy+Immunol&amp;rft.jtitle=Int+Arch+Allergy+Immunol&amp;rft.date=1999&amp;rft.volume=120&amp;rft.issue=2&amp;rft.au=Roux+K&amp;rft.pages=85-99&amp;rft_id=info:pmid/10545762">&#160;</span></li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> <cite style="font-style:normal">Huber R (1980). "Spatial structure of immunoglobulin molecules". <i>Klin Wochenschr</i> <b>58</b> (22): 1217-31. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=6780722" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=6780722">PMID 6780722</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Spatial+structure+of+immunoglobulin+molecules&amp;rft.title=Klin+Wochenschr&amp;rft.jtitle=Klin+Wochenschr&amp;rft.date=1980&amp;rft.volume=58&amp;rft.issue=22&amp;rft.au=Huber+R&amp;rft.pages=1217-31&amp;rft_id=info:pmid/6780722">&#160;</span></li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> <a href="http://www.medicine.uiowa.edu/cigw/fish.htm" class="external text" title="http://www.medicine.uiowa.edu/cigw/fish.htm" rel="nofollow">Fish heavy chain and light chain genes</a></li>
<li id="_note-6"><b><a href="#_ref-6" title="">^</a></b> Eva Bengtén, L. William Clem, Norman W. Miller, Gregory W. Warr and Melanie Wilson. <i>Channel catfish immunoglobulins: Repertoire and expression</i>. Developmental &amp; Comparative Immunology, Volume 30, Issues 1-2, Antibody repertoire development, 2006, Pages 77-92.</li>
<li id="_note-7"><b><a href="#_ref-7" title="">^</a></b> Stein Tore Solem and Jørgen Stenvik. <i>Antibody repertoire development in teleosts--a review with emphasis on salmonids and Gadus morhua L</i>. Developmental &amp; Comparative Immunology, Volume 30, Issues 1-2, Antibody repertoire development, 2006, Pages 57-76.</li>
<li id="_note-8"><b><a href="#_ref-8" title="">^</a></b> J.D. Hansen, E.D. Landis and R.B. Phillips. <i>Discovery of a unique Ig heavy-chain isotype (IgT) in rainbow trout: Implications for a distinctive B cell developmental pathway in teleost fish.</i> Proceedings of the National Academy of Sciences U S A. Volume 102, Issue 19, 2005, pages 6919-24.</li>
<li id="_note-9"><b><a href="#_ref-9" title="">^</a></b> N. Danilova, J. Bussmann, K. Jekosch, L.A Steiner. <i>The immunoglobulin heavy-chain locus in zebrafish: identification and expression of a previously unknown isotype, immunoglobulin Z.</i> Nature Immunology, Volume 6, Issue 3, 2005, pages 295-302.</li>
<li id="_note-10"><b><a href="#_ref-10" title="">^</a></b> H. Dooley and M.F. Flajnik. <i>Antibody repertoire development in cartilaginous fish</i>. Developmental &amp; Comparative Immunology, Volume 30, Issues 1-2, Antibody repertoire development, 2006, Pages 43-56.</li>
<li id="_note-11"><b><a href="#_ref-11" title="">^</a></b> <a href="http://imgt.cines.fr/textes/IMGTindex/antibodies.html" class="external text" title="http://imgt.cines.fr/textes/IMGTindex/antibodies.html" rel="nofollow">IMGT Index</a> Antibodies (or Immunoglobulins).</li>
<li id="_note-12"><b><a href="#_ref-12" title="">^</a></b> <cite style="font-style:normal">Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa E, Bendahman N, Hamers R (1993). "Naturally occurring antibodies devoid of light chains". <i>Nature</i> <b>363</b> (6428): 446-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8502296" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8502296">PMID 8502296</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Naturally+occurring+antibodies+devoid+of+light+chains&amp;rft.title=Nature&amp;rft.jtitle=Nature&amp;rft.date=1993&amp;rft.volume=363&amp;rft.issue=6428&amp;rft.au=Hamers-Casterman+C%2C+Atarhouch+T%2C+Muyldermans+S%2C+Robinson+G%2C+Hamers+C%2C+Songa+E%2C+Bendahman+N%2C+Hamers+R&amp;rft.pages=446-8&amp;rft_id=info:pmid/8502296">&#160;</span></li>
<li id="_note-13"><b><a href="#_ref-13" title="">^</a></b> <cite style="font-style:normal">Conrath K, Wernery U, Muyldermans S, Nguyen V (2003). "Emergence and evolution of functional heavy-chain antibodies in Camelidae". <i>Dev Comp Immunol</i> <b>27</b> (2): 87-103. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12543123" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12543123">PMID 12543123</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Emergence+and+evolution+of+functional+heavy-chain+antibodies+in+Camelidae&amp;rft.title=Dev+Comp+Immunol&amp;rft.jtitle=Dev+Comp+Immunol&amp;rft.date=2003&amp;rft.volume=27&amp;rft.issue=2&amp;rft.au=Conrath+K%2C+Wernery+U%2C+Muyldermans+S%2C+Nguyen+V&amp;rft.pages=87-103&amp;rft_id=info:pmid/12543123">&#160;</span></li>
<li id="_note-14"><b><a href="#_ref-14" title="">^</a></b> <cite style="font-style:normal">Muyldermans S (2001). "Single domain camel antibodies: current status". <i>J Biotechnol</i> <b>74</b> (4): 277-302. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11526908" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11526908">PMID 11526908</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Single+domain+camel+antibodies%3A+current+status&amp;rft.title=J+Biotechnol&amp;rft.jtitle=J+Biotechnol&amp;rft.date=2001&amp;rft.volume=74&amp;rft.issue=4&amp;rft.au=Muyldermans+S&amp;rft.pages=277-302&amp;rft_id=info:pmid/11526908">&#160;</span></li>
<li id="_note-15"><b><a href="#_ref-15" title="">^</a></b> <cite style="font-style:normal">Heyman B (1996). "Complement and Fc-receptors in regulation of the antibody response". <i>Immunol Lett</i> <b>54</b> (2-3): 195-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9052877" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9052877">PMID 9052877</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Complement+and+Fc-receptors+in+regulation+of+the+antibody+response&amp;rft.title=Immunol+Lett&amp;rft.jtitle=Immunol+Lett&amp;rft.date=1996&amp;rft.volume=54&amp;rft.issue=2-3&amp;rft.au=Heyman+B&amp;rft.pages=195-9&amp;rft_id=info:pmid/9052877">&#160;</span></li>
<li id="_note-putnam79"><b><a href="#_ref-putnam79_0" title="">^</a></b> <cite style="font-style:normal">Putnam FW, Liu YS, Low TL (1979). "Primary structure of a human IgA1 immunoglobulin. IV. Streptococcal IgA1 protease, digestion, Fab and Fc fragments, and the complete amino acid sequence of the alpha 1 heavy chain". <i>J Biol Chem</i> <b>254</b> (8): 2865-74. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=107164" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=107164">PMID 107164</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Primary+structure+of+a+human+IgA1+immunoglobulin.+IV.+Streptococcal+IgA1+protease%2C+digestion%2C+Fab+and+Fc+fragments%2C+and+the+complete+amino+acid+sequence+of+the+alpha+1+heavy+chain&amp;rft.title=J+Biol+Chem&amp;rft.jtitle=J+Biol+Chem&amp;rft.date=1979&amp;rft.volume=254&amp;rft.issue=8&amp;rft.au=Putnam+FW%2C+Liu+YS%2C+Low+TL&amp;rft.pages=2865-74&amp;rft_id=info:pmid/107164">&#160;</span></li>
<li id="_note-Wu"><b><a href="#_ref-Wu_0" title="">^</a></b> <cite style="font-style:normal">Wu A, Yazaki P (2000). "Designer genes: recombinant antibody fragments for biological imaging". <i>Q J Nucl Med</i> <b>44</b> (3): 268-83. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11105590" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11105590">PMID 11105590</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Designer+genes%3A+recombinant+antibody+fragments+for+biological+imaging&amp;rft.title=Q+J+Nucl+Med&amp;rft.jtitle=Q+J+Nucl+Med&amp;rft.date=2000&amp;rft.volume=44&amp;rft.issue=3&amp;rft.au=Wu+A%2C+Yazaki+P&amp;rft.pages=268-83&amp;rft_id=info:pmid/11105590">&#160;</span></li>
<li id="_note-16"><b><a href="#_ref-16" title="">^</a></b> <cite style="font-style:normal">Mian I, Bradwell A, Olson A (1991). "Structure, function and properties of antibody binding sites". <i>J Mol Biol</i> <b>217</b> (1): 133-51. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1988675" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1988675">PMID 1988675</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Structure%2C+function+and+properties+of+antibody+binding+sites&amp;rft.title=J+Mol+Biol&amp;rft.jtitle=J+Mol+Biol&amp;rft.date=1991&amp;rft.volume=217&amp;rft.issue=1&amp;rft.au=Mian+I%2C+Bradwell+A%2C+Olson+A&amp;rft.pages=133-51&amp;rft_id=info:pmid/1988675">&#160;</span></li>
<li id="_note-namazee">^ <a href="#_ref-namazee_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-namazee_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Nemazee D (2006). "Receptor editing in lymphocyte development and central tolerance". <i>Nat Rev Immunol</i> <b>6</b> (10): 728-40. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16998507" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16998507">PMID 16998507</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Receptor+editing+in+lymphocyte+development+and+central+tolerance&amp;rft.title=Nat+Rev+Immunol&amp;rft.jtitle=Nat+Rev+Immunol&amp;rft.date=2006&amp;rft.volume=6&amp;rft.issue=10&amp;rft.au=Nemazee+D&amp;rft.pages=728-40&amp;rft_id=info:pmid/16998507">&#160;</span></li>
<li id="_note-Market">^ <a href="#_ref-Market_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Market_1" title=""><sup><i><b>b</b></i></sup></a> Eleonora Market, F. Nina Papavasiliou (2003) <a href="http://biology.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pbio.0000016" class="external text" title="http://biology.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pbio.0000016" rel="nofollow"><i>V(D)J Recombination and the Evolution of the Adaptive Immune System</i></a> <a href="../../../p/l/o/PLoS_Biology_2bb8.html" title="PLoS Biology">PLoS Biology</a>1(1): e16.</li>
<li id="_note-17"><b><a href="#_ref-17" title="">^</a></b> <cite style="font-style:normal">Bergman Y, Cedar H (2004). "A stepwise epigenetic process controls immunoglobulin allelic exclusion". <i>Nat Rev Immunol</i> <b>4</b> (10): 753-61. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15459667" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15459667">PMID 15459667</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=A+stepwise+epigenetic+process+controls+immunoglobulin+allelic+exclusion&amp;rft.title=Nat+Rev+Immunol&amp;rft.jtitle=Nat+Rev+Immunol&amp;rft.date=2004&amp;rft.volume=4&amp;rft.issue=10&amp;rft.au=Bergman+Y%2C+Cedar+H&amp;rft.pages=753-61&amp;rft_id=info:pmid/15459667">&#160;</span></li>
<li id="_note-18"><b><a href="#_ref-18" title="">^</a></b> <cite style="font-style:normal">Diaz M, Casali P (2002). "Somatic immunoglobulin hypermutation". <i>Curr Opin Immunol</i> <b>14</b> (2): 235-40. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11869898" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11869898">PMID 11869898</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Somatic+immunoglobulin+hypermutation&amp;rft.title=Curr+Opin+Immunol&amp;rft.jtitle=Curr+Opin+Immunol&amp;rft.date=2002&amp;rft.volume=14&amp;rft.issue=2&amp;rft.au=Diaz+M%2C+Casali+P&amp;rft.pages=235-40&amp;rft_id=info:pmid/11869898">&#160;</span></li>
<li id="_note-19"><b><a href="#_ref-19" title="">^</a></b> <cite style="font-style:normal">Honjo T, Habu S (1985). "Origin of immune diversity: genetic variation and selection". <i>Annu Rev Biochem</i> <b>54</b>: 803-30. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3927822" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3927822">PMID 3927822</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Origin+of+immune+diversity%3A+genetic+variation+and+selection&amp;rft.title=Annu+Rev+Biochem&amp;rft.jtitle=Annu+Rev+Biochem&amp;rft.date=1985&amp;rft.volume=54&amp;rft.au=Honjo+T%2C+Habu+S&amp;rft.pages=803-30&amp;rft_id=info:pmid/3927822">&#160;</span></li>
<li id="_note-20"><b><a href="#_ref-20" title="">^</a></b> <cite style="font-style:normal">Neuberger M, Ehrenstein M, Rada C, Sale J, Batista F, Williams G, Milstein C (2000). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=10794054" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=10794054" rel="nofollow">journal=Philos Trans R Soc Lond B Biol Sci Memory in the B-cell compartment: antibody affinity maturation</a>" <b>355</b> (1395): 357-60. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10794054" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10794054">PMID 10794054</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Memory+in+the+B-cell+compartment%3A+antibody+affinity+maturation&amp;rft.date=2000&amp;rft.volume=355&amp;rft.issue=1395&amp;rft.au=Neuberger+M%2C+Ehrenstein+M%2C+Rada+C%2C+Sale+J%2C+Batista+F%2C+Williams+G%2C+Milstein+C&amp;rft.pages=357-60&amp;rft_id=info:pmid/10794054&amp;rft_id=http%3A%2F%2Fwww.pubmedcentral.nih.gov%2Farticlerender.fcgi%3Ftool%3Dpubmed%26pubmedid%3D10794054+journal%3DPhilos+Trans+R+Soc+Lond+B+Biol+Sci">&#160;</span></li>
<li id="_note-21"><b><a href="#_ref-21" title="">^</a></b> <cite style="font-style:normal">Pancook J, Beuerlein G, Pecht G, Tang Y, Nie Y, Wu H, Huse W, Watkins J (2001). "In vitro affinity maturation of human IgM antibodies reactive with tumor-associated antigens". <i>Hybrid Hybridomics</i> <b>20</b> (5-6): 383-96. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11839257" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11839257">PMID 11839257</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=In+vitro+affinity+maturation+of+human+IgM+antibodies+reactive+with+tumor-associated+antigens&amp;rft.title=Hybrid+Hybridomics&amp;rft.jtitle=Hybrid+Hybridomics&amp;rft.date=2001&amp;rft.volume=20&amp;rft.issue=5-6&amp;rft.au=Pancook+J%2C+Beuerlein+G%2C+Pecht+G%2C+Tang+Y%2C+Nie+Y%2C+Wu+H%2C+Huse+W%2C+Watkins+J&amp;rft.pages=383-96&amp;rft_id=info:pmid/11839257">&#160;</span></li>
<li id="_note-Ravetch">^ <a href="#_ref-Ravetch_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Ravetch_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Ravetch J, Bolland S (2001). "IgG Fc receptors". <i>Annu Rev Immunol</i> <b>19</b>: 275-90. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11244038" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11244038">PMID 11244038</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=IgG+Fc+receptors&amp;rft.title=Annu+Rev+Immunol&amp;rft.jtitle=Annu+Rev+Immunol&amp;rft.date=2001&amp;rft.volume=19&amp;rft.au=Ravetch+J%2C+Bolland+S&amp;rft.pages=275-90&amp;rft_id=info:pmid/11244038">&#160;</span></li>
<li id="_note-22"><b><a href="#_ref-22" title="">^</a></b> <cite style="font-style:normal">Chippaux J, Goyffon M (1998). "Venoms, antivenoms and immunotherapy". <i>Toxicon</i> <b>36</b> (6): 823-46. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9663690" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9663690">PMID 9663690</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Venoms%2C+antivenoms+and+immunotherapy&amp;rft.title=Toxicon&amp;rft.jtitle=Toxicon&amp;rft.date=1998&amp;rft.volume=36&amp;rft.issue=6&amp;rft.au=Chippaux+J%2C+Goyffon+M&amp;rft.pages=823-46&amp;rft_id=info:pmid/9663690">&#160;</span></li>
<li id="_note-Weiss1"><b><a href="#_ref-Weiss1_0" title="">^</a></b> <cite style="font-style:normal">Weiss R (2001). "Gulliver's travels in HIVland". <i>Nature</i> <b>410</b> (6831): 963-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11309625" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11309625">PMID 11309625</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Gulliver%27s+travels+in+HIVland&amp;rft.title=Nature&amp;rft.jtitle=Nature&amp;rft.date=2001&amp;rft.volume=410&amp;rft.issue=6831&amp;rft.au=Weiss+R&amp;rft.pages=963-7&amp;rft_id=info:pmid/11309625">&#160;</span></li>
<li id="_note-23"><b><a href="#_ref-23" title="">^</a></b> <cite style="font-style:normal">Rus H, Cudrici C, Niculescu F (2005). "The role of the complement system in innate immunity". <i>Immunol Res</i> <b>33</b> (2): 103-12. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16234578" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16234578">PMID 16234578</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+role+of+the+complement+system+in+innate+immunity&amp;rft.title=Immunol+Res&amp;rft.jtitle=Immunol+Res&amp;rft.date=2005&amp;rft.volume=33&amp;rft.issue=2&amp;rft.au=Rus+H%2C+Cudrici+C%2C+Niculescu+F&amp;rft.pages=103-12&amp;rft_id=info:pmid/16234578">&#160;</span></li>
<li id="_note-24"><b><a href="#_ref-24" title="">^</a></b> <a href="http://www.elispot-analyzers.de/english/elisa-animation.html" class="external text" title="http://www.elispot-analyzers.de/english/elisa-animation.html" rel="nofollow">Animated depictions of how antibodies are used in</a> <a href="../../../e/l/i/ELISA_6661.html" title="ELISA">ELISA</a> assays</li>
<li id="_note-Dean">^ <a href="#_ref-Dean_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Dean_1" title=""><sup><i><b>b</b></i></sup></a> <cite class="book" style="font-style:normal" id="Reference-Dean-2005">Dean, Laura (2005). "<a href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=rbcantigen.chapter.ch4" class="external text" title="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=rbcantigen.chapter.ch4" rel="nofollow">Chapter 4: Hemolytic disease of the newborn</a>", <i>Blood Groups and Red Cell Antigens</i>. NCBI Bethesda (MD): National Library of Medicine (US),.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Blood+Groups+and+Red+Cell+Antigens&amp;rft.title=Blood+Groups+and+Red+Cell+Antigens&amp;rft.atitle=Chapter+4%3A+Hemolytic+disease+of+the+newborn&amp;rft.aulast=Dean&amp;rft.aufirst=Laura&amp;rft.date=2005&amp;rft.pub=National+Library+of+Medicine+%28US%29%2C&amp;rft.place=NCBI+Bethesda+%28MD%29">&#160;</span></li>
<li id="_note-25"><b><a href="#_ref-25" title="">^</a></b> <cite style="font-style:normal">Feldmann M, Maini R (2001). "Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?". <i>Annu Rev Immunol</i> <b>19</b>: 163-96. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11244034" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11244034">PMID 11244034</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Anti-TNF+alpha+therapy+of+rheumatoid+arthritis%3A+what+have+we+learned%3F&amp;rft.title=Annu+Rev+Immunol&amp;rft.jtitle=Annu+Rev+Immunol&amp;rft.date=2001&amp;rft.volume=19&amp;rft.au=Feldmann+M%2C+Maini+R&amp;rft.pages=163-96&amp;rft_id=info:pmid/11244034">&#160;</span></li>
<li id="_note-26"><b><a href="#_ref-26" title="">^</a></b> <cite style="font-style:normal">Doggrell S (2003). "Is natalizumab a breakthrough in the treatment of multiple sclerosis?". <i>Expert Opin Pharmacother</i> <b>4</b> (6): 999-1001. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12783595" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12783595">PMID 12783595</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Is+natalizumab+a+breakthrough+in+the+treatment+of+multiple+sclerosis%3F&amp;rft.title=Expert+Opin+Pharmacother&amp;rft.jtitle=Expert+Opin+Pharmacother&amp;rft.date=2003&amp;rft.volume=4&amp;rft.issue=6&amp;rft.au=Doggrell+S&amp;rft.pages=999-1001&amp;rft_id=info:pmid/12783595">&#160;</span></li>
<li id="_note-27"><b><a href="#_ref-27" title="">^</a></b> <cite style="font-style:normal">Krueger G, Langley R, Leonardi C, Yeilding N, Guzzo C, Wang Y, Dooley L, Lebwohl M (2007). "A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis". <i>N Engl J Med</i> <b>356</b> (6): 580-92. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17287478" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17287478">PMID 17287478</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=A+human+interleukin-12%2F23+monoclonal+antibody+for+the+treatment+of+psoriasis&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2007&amp;rft.volume=356&amp;rft.issue=6&amp;rft.au=Krueger+G%2C+Langley+R%2C+Leonardi+C%2C+Yeilding+N%2C+Guzzo+C%2C+Wang+Y%2C+Dooley+L%2C+Lebwohl+M&amp;rft.pages=580-92&amp;rft_id=info:pmid/17287478">&#160;</span></li>
<li id="_note-28"><b><a href="#_ref-28" title="">^</a></b> <cite style="font-style:normal">Plosker G, Figgitt D (2003). "Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia". <i>Drugs</i> <b>63</b> (8): 803-43. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12662126" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12662126">PMID 12662126</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Rituximab%3A+a+review+of+its+use+in+non-Hodgkin%27s+lymphoma+and+chronic+lymphocytic+leukaemia&amp;rft.title=Drugs&amp;rft.jtitle=Drugs&amp;rft.date=2003&amp;rft.volume=63&amp;rft.issue=8&amp;rft.au=Plosker+G%2C+Figgitt+D&amp;rft.pages=803-43&amp;rft_id=info:pmid/12662126">&#160;</span></li>
<li id="_note-29"><b><a href="#_ref-29" title="">^</a></b> <cite style="font-style:normal">Vogel C, Cobleigh M, Tripathy D, Gutheil J, Harris L, Fehrenbacher L, Slamon D, Murphy M, Novotny W, Burchmore M, Shak S, Stewart S (2001). "First-line Herceptin monotherapy in metastatic breast cancer". <i>Oncology</i> <b>61 Suppl 2</b>: 37-42. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11694786" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11694786">PMID 11694786</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=First-line+Herceptin+monotherapy+in+metastatic+breast+cancer&amp;rft.title=Oncology&amp;rft.jtitle=Oncology&amp;rft.date=2001&amp;rft.volume=61+Suppl+2&amp;rft.au=Vogel+C%2C+Cobleigh+M%2C+Tripathy+D%2C+Gutheil+J%2C+Harris+L%2C+Fehrenbacher+L%2C+Slamon+D%2C+Murphy+M%2C+Novotny+W%2C+Burchmore+M%2C+Shak+S%2C+Stewart+S&amp;rft.pages=37-42&amp;rft_id=info:pmid/11694786">&#160;</span></li>
<li id="_note-30"><b><a href="#_ref-30" title="">^</a></b> <cite style="font-style:normal">LeBien T (2000). "<a href="http://bloodjournal.hematologylibrary.org/cgi/content/full/96/1/9" class="external text" title="http://bloodjournal.hematologylibrary.org/cgi/content/full/96/1/9" rel="nofollow">Fates of human B-cell precursors</a>". <i>Blood</i> <b>96</b> (1): 9-23. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10891425" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10891425">PMID 10891425</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Fates+of+human+B-cell+precursors&amp;rft.title=Blood&amp;rft.jtitle=Blood&amp;rft.date=2000&amp;rft.volume=96&amp;rft.issue=1&amp;rft.au=LeBien+T&amp;rft.pages=9-23&amp;rft_id=info:pmid/10891425&amp;rft_id=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcgi%2Fcontent%2Ffull%2F96%2F1%2F9">&#160;</span></li>
<li id="_note-USC"><b><a href="#_ref-USC_0" title="">^</a></b> <a href="http://pathmicro.med.sc.edu/ghaffar/immunization.htm" class="external text" title="http://pathmicro.med.sc.edu/ghaffar/immunization.htm" rel="nofollow">Microbiology and Immunology On-Line Textbook</a>: USC School of Medicine</li>
<li id="_note-31"><b><a href="#_ref-31" title="">^</a></b> <cite style="font-style:normal">Fung Kee Fung K, Eason E, Crane J, Armson A, De La Ronde S, Farine D, Keenan-Lindsay L, Leduc L, Reid G, Aerde J, Wilson R, Davies G, Désilets V, Summers A, Wyatt P, Young D (2003). "Prevention of Rh alloimmunization". <i>J Obstet Gynaecol Can</i> <b>25</b> (9): 765-73. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12970812" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12970812">PMID 12970812</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Prevention+of+Rh+alloimmunization&amp;rft.title=J+Obstet+Gynaecol+Can&amp;rft.jtitle=J+Obstet+Gynaecol+Can&amp;rft.date=2003&amp;rft.volume=25&amp;rft.issue=9&amp;rft.au=Fung+Kee+Fung+K%2C+Eason+E%2C+Crane+J%2C+Armson+A%2C+De+La+Ronde+S%2C+Farine+D%2C+Keenan-Lindsay+L%2C+Leduc+L%2C+Reid+G%2C+Aerde+J%2C+Wilson+R%2C+Davies+G%2C+D%C3%A9silets+V%2C+Summers+A%2C+Wyatt+P%2C+Young+D&amp;rft.pages=765-73&amp;rft_id=info:pmid/12970812">&#160;</span></li>
<li id="_note-32"><b><a href="#_ref-32" title="">^</a></b> <cite style="font-style:normal">Urbaniak S, Greiss M (2000). "RhD haemolytic disease of the fetus and the newborn". <i>Blood Rev</i> <b>14</b> (1): 44-61. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10805260" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10805260">PMID 10805260</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=RhD+haemolytic+disease+of+the+fetus+and+the+newborn&amp;rft.title=Blood+Rev&amp;rft.jtitle=Blood+Rev&amp;rft.date=2000&amp;rft.volume=14&amp;rft.issue=1&amp;rft.au=Urbaniak+S%2C+Greiss+M&amp;rft.pages=44-61&amp;rft_id=info:pmid/10805260">&#160;</span></li>
<li id="_note-Stecher">^ <a href="#_ref-Stecher_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Stecher_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Brehm-Stecher B, Johnson E (2004). "<a href="http://mmbr.asm.org/cgi/content/full/68/3/538?view=long&amp;pmid=15353569" class="external text" title="http://mmbr.asm.org/cgi/content/full/68/3/538?view=long&amp;pmid=15353569" rel="nofollow">Single-cell microbiology: tools, technologies, and applications</a>". <i>Microbiol Mol Biol Rev</i> <b>68</b> (3): 538-59. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15353569" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15353569">PMID 15353569</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Single-cell+microbiology%3A+tools%2C+technologies%2C+and+applications&amp;rft.title=Microbiol+Mol+Biol+Rev&amp;rft.jtitle=Microbiol+Mol+Biol+Rev&amp;rft.date=2004&amp;rft.volume=68&amp;rft.issue=3&amp;rft.au=Brehm-Stecher+B%2C+Johnson+E&amp;rft.pages=538-59&amp;rft_id=info:pmid/15353569&amp;rft_id=http%3A%2F%2Fmmbr.asm.org%2Fcgi%2Fcontent%2Ffull%2F68%2F3%2F538%3Fview%3Dlong%26pmid%3D15353569">&#160;</span></li>
<li id="_note-33"><b><a href="#_ref-33" title="">^</a></b> <cite style="font-style:normal">Williams N (2000). "Immunoprecipitation procedures". <i>Methods Cell Biol</i> <b>62</b>: 449-53. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10503210" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10503210">PMID 10503210</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Immunoprecipitation+procedures&amp;rft.title=Methods+Cell+Biol&amp;rft.jtitle=Methods+Cell+Biol&amp;rft.date=2000&amp;rft.volume=62&amp;rft.au=Williams+N&amp;rft.pages=449-53&amp;rft_id=info:pmid/10503210">&#160;</span></li>
<li id="_note-34"><b><a href="#_ref-34" title="">^</a></b> <cite style="font-style:normal">Kurien B, Scofield R (2006). "Western blotting". <i>Methods</i> <b>38</b> (4): 283-93. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16483794" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16483794">PMID 16483794</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Western+blotting&amp;rft.title=Methods&amp;rft.jtitle=Methods&amp;rft.date=2006&amp;rft.volume=38&amp;rft.issue=4&amp;rft.au=Kurien+B%2C+Scofield+R&amp;rft.pages=283-93&amp;rft_id=info:pmid/16483794">&#160;</span></li>
<li id="_note-35"><b><a href="#_ref-35" title="">^</a></b> <cite style="font-style:normal">Scanziani E. "Immunohistochemical staining of fixed tissues". <i>Methods Mol Biol</i> <b>104</b>: 133-40. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9711649" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9711649">PMID 9711649</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Immunohistochemical+staining+of+fixed+tissues&amp;rft.title=Methods+Mol+Biol&amp;rft.jtitle=Methods+Mol+Biol&amp;rft.volume=104&amp;rft.au=Scanziani+E&amp;rft.pages=133-40&amp;rft_id=info:pmid/9711649">&#160;</span></li>
<li id="_note-36"><b><a href="#_ref-36" title="">^</a></b> <cite style="font-style:normal">Kabir S. "Immunoglobulin purification by affinity chromatography using protein A mimetic ligands prepared by combinatorial chemical synthesis". <i>Immunol Invest</i> <b>31</b> (3-4): 263-78. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12472184" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12472184">PMID 12472184</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Immunoglobulin+purification+by+affinity+chromatography+using+protein+A+mimetic+ligands+prepared+by+combinatorial+chemical+synthesis&amp;rft.title=Immunol+Invest&amp;rft.jtitle=Immunol+Invest&amp;rft.volume=31&amp;rft.issue=3-4&amp;rft.au=Kabir+S&amp;rft.pages=263-78&amp;rft_id=info:pmid/12472184">&#160;</span></li>
<li id="_note-37"><b><a href="#_ref-37" title="">^</a></b> <a href="http://www.elispot-analyzers.de/english/elispot-animation.html" class="external text" title="http://www.elispot-analyzers.de/english/elispot-animation.html" rel="nofollow">Animated depictions of how antibodies are used in</a> <a href="../../../e/l/i/ELISPOT_7d76.html" title="ELISPOT">ELISPOT</a> assays</li>
</ol>
</div>
<p><a name="Additional_images" id="Additional_images"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: Additional images">edit</a>]</span> <span class="mw-headline">Additional images</span></h2>
<div class="infobox sisterproject">
<div class="floatleft"><span><a href="../../../c/o/m/Image%7ECommons-logo.svg_62a0.html" class="image" title=""><img src="../../../upload/thumb/4/4a/Commons-logo.svg/50px-Commons-logo.svg.png" alt="" width="50" height="67" longdesc="../../../c/o/m/Image%7ECommons-logo.svg_62a0.html" /></a></span></div>
<div style="margin-left: 60px;"><a href="../../../w/i/k/Wikimedia_Commons_7b57.html" title="Wikimedia Commons">Wikimedia Commons</a> has media related to:
<div style="margin-left: 10px;"><i><b><a href="http://commons.wikimedia.org/wiki/Category:Antibodies" class="extiw" title="commons:Category:Antibodies">Antibodies</a></b></i></div>
</div>
</div>
<table class="gallery" cellspacing="0" cellpadding="0">
<tr>
<td>
<div class="gallerybox" style="width: 150px;">
<div class="thumb" style="padding: 15px 0; width: 150px;"><a href="../../../a/n/t/Image%7EAntibody_scheme.svg_2614.html" title="Image:Antibody scheme.svg"><img src="../../../upload/shared/thumb/3/35/Antibody_scheme.svg/120px-Antibody_scheme.svg.png" width="120" height="115" alt="" /></a></div>
<div class="gallerytext">
<p>Antibody scheme</p>
<p><br /></p>
</div>
</div>
</td>
<td>
<div class="gallerybox" style="width: 150px;">
<div class="thumb" style="padding: 13px 0; width: 150px;"><a href="../../../a/n/t/Image%7EAnticorps.png_7d4b.html" title="Image:Anticorps.png"><img src="../../../upload/shared/thumb/7/78/Anticorps.png/119px-Anticorps.png" width="119" height="120" alt="" /></a></div>
<div class="gallerytext">
<p>Antibody</p>
<p><br /></p>
</div>
</div>
</td>
<td>
<div class="gallerybox" style="width: 150px;">
<div class="thumb" style="padding: 13px 0; width: 150px;"><a href="../../../i/m/m/Image%7EImmunoglobulin_basic_unit.svg_1b12.html" title="Image:Immunoglobulin basic unit.svg"><img src="../../../upload/shared/thumb/1/19/Immunoglobulin_basic_unit.svg/120px-Immunoglobulin_basic_unit.svg.png" width="120" height="120" alt="" /></a></div>
<div class="gallerytext">
<p>Immunoglobulin basic unit</p>
<p><br /></p>
</div>
</div>
</td>
<td>
<div class="gallerybox" style="width: 150px;">
<div class="thumb" style="padding: 13px 0; width: 150px;"><a href="../../../s/c/f/Image%7EScfv1.png_e84d.html" title="Image:Scfv1.png"><img src="../../../upload/thumb/c/c2/Scfv1.png/115px-Scfv1.png" width="115" height="120" alt="" /></a></div>
<div class="gallerytext">
<p>A Y-shaped antibody molecule.</p>
<p><br /></p>
</div>
</div>
</td>
</tr>
</table>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antibody.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.path.cam.ac.uk/~mrc7/mikeimages.html" class="external text" title="http://www.path.cam.ac.uk/~mrc7/mikeimages.html" rel="nofollow">Mike's Immunoglobulin Structure/Function Page</a> Cambridge University</li>
<li><a href="http://www.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb21_1.html" class="external text" title="http://www.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb21_1.html" rel="nofollow">Antibodies as the PDB molecule of the month</a> Discussion of the structure of antibodies.</li>
<li><a href="http://pathmicro.med.sc.edu/mayer/IgStruct2000.htm" class="external text" title="http://pathmicro.med.sc.edu/mayer/IgStruct2000.htm" rel="nofollow">Microbiology and Immunology On-line Textbook</a> The University of South Carolina</li>
<li><a href="http://users.path.ox.ac.uk/~scobbold/tig/new1/mabth.html" class="external text" title="http://users.path.ox.ac.uk/~scobbold/tig/new1/mabth.html" rel="nofollow">A hundred years of antibody therapy</a> History and applications of antibodies in the treatment of disease.</li>
<li><a href="http://www.cellsalive.com/antibody.htm" class="external text" title="http://www.cellsalive.com/antibody.htm" rel="nofollow">How Lymphocytes Produce Antibody</a> from Cells Alive!</li>
<li><a href="http://www.ii.bham.ac.uk/clinicalimmunology/CISimagelibrary/" class="external text" title="http://www.ii.bham.ac.uk/clinicalimmunology/CISimagelibrary/" rel="nofollow">Antibody applications</a> Fluorescent antibody image library, University of Birmingham</li>
<li><a href="http://www.antibodypatterns.com/" class="external text" title="http://www.antibodypatterns.com/" rel="nofollow">Images produced using antibodies</a></li>
</ul>
<div class="NavFrame" style="clear:both;">
<div class="NavHead" style="background:#efefef;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../i/m/m/Template%7EImmune_system_e042.html" title="Template:Immune system"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../i/m/m/Template%7EImmune_system_e042.html" class="external text" title="http://en.wikipedia.org../../../i/m/m/Template%7EImmune_system_e042.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><a href="../../../i/m/m/Immune_system.html" title="Immune system">Immune system</a></b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><a href="../../../a/d/a/Adaptive_immune_system.html" title="Adaptive immune system">Adaptive immune system</a> - <a href="../../../i/n/n/Innate_immune_system.html" title="Innate immune system">Innate immune system</a> - <a href="../../../h/u/m/Humoral_immunity.html" title="Humoral immunity">Humoral immune system</a> - <a href="../../../c/e/l/Cell-mediated_immunity.html" title="Cell-mediated immunity">Cellular immune system</a></p>
<p><a href="../../../l/y/m/Lymphatic_system.html" title="Lymphatic system">Lymphatic system</a> - <a href="../../../i/n/f/Inflammation.html" title="Inflammation">Inflammation</a> - <a href="../../../c/o/m/Complement_system.html" title="Complement system">Complement system</a> (<a href="../../../c/l/a/Classical_complement_pathway.html" title="Classical complement pathway">Classical</a>, <a href="../../../a/l/t/Alternative_complement_pathway.html" title="Alternative complement pathway">Alternative</a>, <a href="../../../m/a/n/Mannan-binding_lectin_pathway.html" title="Mannan-binding lectin pathway">Lectin</a>) - <a href="../../../c/y/t/Cytokine.html" title="Cytokine">Cytokines</a> - <a href="../../../w/h/i/White_blood_cell.html" title="White blood cell">White blood cells</a> - <strong class="selflink">Antibody</strong> - <a href="../../../a/n/t/Antigen.html" title="Antigen">Antigen</a> - <a href="../../../a/n/t/Antigen-presenting_cell.html" title="Antigen-presenting cell">APC</a> - <a href="../../../m/a/j/Major_histocompatibility_complex.html" title="Major histocompatibility complex">MHC</a></p>
<p><a href="../../../i/m/m/Immunity_%28medical%29.html" title="Immunity (medical)">Immunity</a> - <a href="../../../a/u/t/Autoimmunity.html" title="Autoimmunity">Autoimmunity</a> - <a href="../../../i/m/m/Immune_tolerance.html" title="Immune tolerance">Tolerance</a> (<a href="../../../c/e/n/Central_tolerance.html" title="Central tolerance">Central</a>) - <a href="../../../i/m/m/Immunodeficiency.html" title="Immunodeficiency">Immunodeficiency</a></p>
<p><a href="../../../p/h/a/Phagocyte.html" title="Phagocyte">Phagocyte</a> - <a href="../../../r/e/t/Reticuloendothelial_system.html" title="Reticuloendothelial system">Reticuloendothelial system</a></p>
</div>
</div>
<div class="NavFrame" style="clear:both;">
<div class="NavHead" style="background:#e7dcc3;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../g/l/o/Template%7EGlobulins_6e56.html" title="Template:Globulins"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../g/l/o/Template%7EGlobulins_6e56.html" class="external text" title="http://en.wikipedia.org../../../g/l/o/Template%7EGlobulins_6e56.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><a href="../../../p/r/o/Protein.html" title="Protein">Proteins</a>: <a href="../../../g/l/o/Globulin.html" title="Globulin">globulins</a></b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><a href="../../../b/e/t/Beta-lactoglobulin.html" title="Beta-lactoglobulin">Lactoglobulin</a> (<a href="../../../l/a/c/Lactoferrin.html" title="Lactoferrin">Lactoferrin</a>) - <a href="../../../t/h/y/Thyroglobulin.html" title="Thyroglobulin">Thyroglobulin</a></p>
<p><i><a href="../../../b/l/o/Blood_plasma.html" title="Blood plasma">Serum</a>:</i> <a href="../../../a/l/p/Alpha_globulin.html" title="Alpha globulin">Alpha globulins</a> - <a href="../../../b/e/t/Beta_globulins.html" title="Beta globulins">Beta globulins</a> - <a href="../../../f/i/b/Fibronectin.html" title="Fibronectin">Fibronectins</a> - <strong class="selflink">Immunoglobulins</strong> - <a href="../../../m/a/c/Macroglobulin.html" title="Macroglobulin">Macroglobulins</a> - <a href="../../../t/r/a/Transcobalamins.html" title="Transcobalamins">Transcobalamins</a></p>
</div>
</div>
<div class="NavFrame" style="clear:both;">
<div class="NavHead" style="background:#e7dcc3;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../i/m/m/Template%7EImmune_proteins_4471.html" title="Template:Immune proteins"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../i/m/m/Template%7EImmune_proteins_4471.html" class="external text" title="http://en.wikipedia.org../../../i/m/m/Template%7EImmune_proteins_4471.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><a href="../../../i/m/m/Immune_system.html" title="Immune system">Immune system</a> <a href="../../../p/r/o/Protein.html" title="Protein">proteins</a></b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><a href="../../../c/o/m/Complement_membrane_attack_complex.html" title="Complement membrane attack complex">MAC&#160;complex</a> - <a href="../../../n/a/n/Nanobodies.html" title="Nanobodies">Nanobodies</a> - <a href="../../../p/e/r/Perforin.html" title="Perforin">Perforin</a> - <strong class="selflink">Antibodies</strong> (<a href="../../../i/m/m/Immunoglobulin_A_cd23.html" title="Immunoglobulin A">IgA</a>, <a href="../../../i/m/m/Immunoglobulin_D_c792.html" title="Immunoglobulin D">IgD</a>, <a href="../../../i/m/m/Immunoglobulin_E_8efa.html" title="Immunoglobulin E">IgE</a>, <a href="../../../i/m/m/Immunoglobulin_G_73c5.html" title="Immunoglobulin G">IgG</a>, <a href="../../../i/m/m/Immunoglobulin_M_28e9.html" title="Immunoglobulin M">IgM</a>)</p>
</div>
</div>
<p><span id="interwiki-vi-fa"></span></p>

<!-- 
Pre-expand include size: 220746 bytes
Post-expand include size: 83745 bytes
Template argument size: 51776 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/n/t/Antibody.html">http://en.wikipedia.org../../../a/n/t/Antibody.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../i/m/m/Category%7EImmune_system_18f7.html" title="Category:Immune system">Immune system</a></span> | <span dir='ltr'><a href="../../../g/l/y/Category%7EGlycoproteins_a2e8.html" title="Category:Glycoproteins">Glycoproteins</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/n/t/Antibody.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/n/t/Talk%7EAntibody_844c.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Antibody">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../bn/%E0%A6%85/%E0%A7%8D/%E0%A6%AF/%E0%A6%85%E0%A7%8D%E0%A6%AF%E0%A6%BE%E0%A6%A8%E0%A7%8D%E0%A6%9F%E0%A6%BF%E0%A6%AC%E0%A6%A1%E0%A6%BF.html">বাংলা</a>
	      </li>
	      	      <li>
	      <a href="../../../../bg/%D0%B0/%D0%BD/%D1%82/%D0%90%D0%BD%D1%82%D0%B8%D1%82%D1%8F%D0%BB%D0%BE.html">Български</a>
	      </li>
	      	      <li>
	      <a href="../../../../cs/p/r/o/Protil%C3%A1tka.html">Česky</a>
	      </li>
	      	      <li>
	      <a href="../../../../da/a/n/t/Antistof_%28biologi%29.html">Dansk</a>
	      </li>
	      	      <li>
	      <a href="../../../../de/a/n/t/Antik%C3%B6rper.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/a/n/t/Anticuerpo.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../fa/%D9%BE/%D8%A7/%D8%AF/%D9%BE%D8%A7%D8%AF%D8%AA%D9%86.html">فارسی</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/a/n/t/Anticorps.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../ko/%ED%95%AD/%EC%B2%B4/_/%ED%95%AD%EC%B2%B4.html">한국어</a>
	      </li>
	      	      <li>
	      <a href="../../../../it/a/n/t/Anticorpo.html">Italiano</a>
	      </li>
	      	      <li>
	      <a href="../../../../he/%D7%A0/%D7%95/%D7%92/%D7%A0%D7%95%D7%92%D7%93%D7%9F.html">עברית</a>
	      </li>
	      	      <li>
	      <a href="../../../../lt/a/n/t/Antik%C5%ABnis.html">Lietuvių</a>
	      </li>
	      	      <li>
	      <a href="../../../../hu/e/l/l/Ellenanyag.html">Magyar</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/i/m/m/Immunoglobuline.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E6%8A%97/%E4%BD%93/_/%E6%8A%97%E4%BD%93.html">日本語</a>
	      </li>
	      	      <li>
	      <a href="../../../../no/a/n/t/Antistoff.html">‪Norsk (bokmål)‬</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/p/r/z/Przeciwcia%C5%82o.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../pt/i/m/u/Imunoglobulina.html">Português</a>
	      </li>
	      	      <li>
	      <a href="../../../../ru/%D0%B0/%D0%BD/%D1%82/%D0%90%D0%BD%D1%82%D0%B8%D1%82%D0%B5%D0%BB%D0%BE.html">Русский</a>
	      </li>
	      	      <li>
	      <a href="../../../../simple/a/n/t/Antibody.html">Simple English</a>
	      </li>
	      	      <li>
	      <a href="../../../../sk/p/r/o/Protil%C3%A1tka.html">Slovenčina</a>
	      </li>
	      	      <li>
	      <a href="../../../../sr/%D0%B0/%D0%BD/%D1%82/%D0%90%D0%BD%D1%82%D0%B8%D1%82%D0%B5%D0%BB%D0%BE.html">Српски / Srpski</a>
	      </li>
	      	      <li>
	      <a href="../../../../fi/v/a/s/Vasta-aine.html">Suomi</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/a/n/t/Antikropp.html">Svenska</a>
	      </li>
	      	      <li>
	      <a href="../../../../th/%E0%B9%81/%E0%B8%AD/%E0%B8%99/%E0%B9%81%E0%B8%AD%E0%B8%99%E0%B8%95%E0%B8%B4%E0%B8%9A%E0%B8%AD%E0%B8%94%E0%B8%B5.html">ไทย</a>
	      </li>
	      	      <li>
	      <a href="../../../../vi/k/h/%C3%A1/Kh%C3%A1ng_th%E1%BB%83.html">Tiếng Việt</a>
	      </li>
	      	      <li>
	      <a href="../../../../tr/a/n/t/Antikor.html">Türkçe</a>
	      </li>
	      	      <li>
	      <a href="../../../../uk/%D0%B0/%D0%BD/%D1%82/%D0%90%D0%BD%D1%82%D0%B8%D1%82%D1%96%D0%BB%D0%BE.html">Українська</a>
	      </li>
	      	      <li>
	      <a href="../../../../zh/%E6%8A%97/%E4%BD%93/_/%E6%8A%97%E4%BD%93.html">中文</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 03:14, 5 April 2007 by Wikipedia user <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>. Based on work by Wikipedia user(s) <a href="../../../c/i/a/User%7ECiar_186a.html" title="User:Ciar">Ciar</a>, <a href="../../../t/i/m/User%7ETimVickers_d98e.html" title="User:TimVickers">TimVickers</a>, <a href="../../../m/a/r/User%7EMartinBot_3f64.html" title="User:MartinBot">MartinBot</a>, <a href="../../../p/h/y/User%7EPhydend_cfe6.html" title="User:Phydend">Phydend</a>, <a href="../../../a/n/a/User%7EAnas_Salloum_27fd.html" title="User:Anas Salloum">Anas Salloum</a>, <a href="../../../x/e/t/User%7EXett_cee9.html" title="User:Xett">Xett</a>, <a href="../../../d/o/1/User%7EDO11.10_882e.html" title="User:DO11.10">DO11.10</a>, <a href="../../../h/a/r/User%7EHarryboyles_b16b.html" title="User:Harryboyles">Harryboyles</a>, <a href="../../../j/o/n/User%7EJon186_ab8e.html" title="User:Jon186">Jon186</a>, Rajanthampi, <a href="../../../m/a/t/User%7EMattb112885_4ad1.html" title="User:Mattb112885">Mattb112885</a>, <a href="../../../s/e/l/User%7ESelket_adc6.html" title="User:Selket">Selket</a>, Chaz1066, <a href="../../../l/b/k/User%7ELBK74_f524.html" title="User:LBK74">LBK74</a>, <a href="../../../w/o/o/User%7EWoohookitty_27d9.html" title="User:Woohookitty">Woohookitty</a>, <a href="../../../k/a/s/User%7EKastoun_860c.html" title="User:Kastoun">Kastoun</a>, Cabbydriver, <a href="../../../a/f/l/User%7EAfluent_Rider_4c56.html" title="User:Afluent Rider">Afluent Rider</a>, Timferno, <a href="../../../t/a/c/User%7ETaco325i_a7ce.html" title="User:Taco325i">Taco325i</a>, Renji143, <a href="../../../p/o/l/User%7EPoliticalJunkie_1864.html" title="User:PoliticalJunkie">PoliticalJunkie</a>, <a href="../../../k/e/e/User%7EKeesiewonder_39bb.html" title="User:Keesiewonder">Keesiewonder</a>, <a href="../../../s/e/r/User%7ESerephine_0d7d.html" title="User:Serephine">Serephine</a>, Opelio, <a href="../../../d/h/n/User%7EDHN-bot_8c4a.html" title="User:DHN-bot">DHN-bot</a>, <a href="../../../s/a/n/User%7ESanderB_1085.html" title="User:SanderB">SanderB</a>, <a href="../../../b/i/g/User%7EBigrTex_3847.html" title="User:BigrTex">BigrTex</a>, <a href="../../../j/i/m/User%7EJim_Douglas_5faf.html" title="User:Jim Douglas">Jim Douglas</a>, <a href="../../../a/h/o/User%7EAhoerstemeier_88c8.html" title="User:Ahoerstemeier">Ahoerstemeier</a>, <a href="../../../f/e/e/User%7EFeezo_67f9.html" title="User:Feezo">Feezo</a>, <a href="../../../c/r/y/User%7ECrystallina_cbad.html" title="User:Crystallina">Crystallina</a>, <a href="../../../p/v/o/User%7EPvosta_2ba4.html" title="User:Pvosta">Pvosta</a>, Bioinformin, <a href="../../../w/o/u/User%7EWouterstomp_b006.html" title="User:Wouterstomp">Wouterstomp</a>, <a href="../../../j/e/_/User%7EJe_at_uwo_2966.html" title="User:Je at uwo">Je at uwo</a>, TorbenBarington, <a href="../../../a/p/p/User%7EAppraiser_5597.html" title="User:Appraiser">Appraiser</a>, <a href="../../../i/x/f/User%7EIxfd64_14d3.html" title="User:Ixfd64">Ixfd64</a>, Ghermans, <a href="../../../b/o/t/User%7EBot-Schafter_1a19.html" title="User:Bot-Schafter">Bot-Schafter</a>, <a href="../../../y/a/m/User%7EYamaguchi%E5%85%88%E7%94%9F_6995.html" title="User:Yamaguchi先生">Yamaguchi先生</a>, Lefranc, <a href="../../../h/u/s/User%7EHusond_60c3.html" title="User:Husond">Husond</a>, Argrig, <a href="../../../g/a/k/User%7EGak_da6b.html" title="User:Gak">Gak</a>, <a href="../../../h/i/d/User%7EHide%26Reason_b5e8.html" title="User:Hide&amp;Reason">Hide&amp;Reason</a>, Akhil999in, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../d/e/e/User%7EDeetdeet_53b9.html" title="User:Deetdeet">Deetdeet</a>, <a href="../../../m/i/x/User%7EMixel_256f.html" title="User:Mixel">Mixel</a>, <a href="../../../d/r/e/User%7EDreadlocke_8280.html" title="User:Dreadlocke">Dreadlocke</a>, Sergeymk, <a href="../../../c/h/o/User%7EChobot_0dce.html" title="User:Chobot">Chobot</a>, Audchen, Nevo taaseh, Drangscleaner, Akira1984, <a href="../../../s/a/d/User%7ESadi_Carnot_1e85.html" title="User:Sadi Carnot">Sadi Carnot</a>, <a href="../../../a/l/p/User%7EAlphachimpbot_48b3.html" title="User:Alphachimpbot">Alphachimpbot</a>, <a href="../../../r/e/l/User%7ERelentlessRouge_10ff.html" title="User:RelentlessRouge">RelentlessRouge</a>, <a href="../../../g/r/c/User%7EGrcampbell_a0e7.html" title="User:Grcampbell">Grcampbell</a>, <a href="../../../t/r/i/User%7ETri6ky_6a7b.html" title="User:Tri6ky">Tri6ky</a>, <a href="../../../t/d/i/User%7ETdivala_1c68.html" title="User:Tdivala">Tdivala</a>, Molecularbio, <a href="../../../c/o/p/User%7ECopperKettle_9495.html" title="User:CopperKettle">CopperKettle</a>, <a href="../../../s/_/s/User%7ES_Sepp_9da0.html" title="User:S Sepp">S Sepp</a>, <a href="../../../w/e/g/User%7EWeggeBot_7120.html" title="User:WeggeBot">WeggeBot</a>, <a href="../../../b/r/a/User%7EBrazucs_6917.html" title="User:Brazucs">Brazucs</a>, <a href="../../../s/e/a/User%7ESeans_Potato_Business_0fbe.html" title="User:Seans Potato Business">Seans Potato Business</a>, Whosthedaddy, <a href="../../../p/g/a/User%7EPgan002_fb49.html" title="User:Pgan002">Pgan002</a>, <a href="../../../j/a/m/User%7EJames_McNally_d8fa.html" title="User:James McNally">James McNally</a>, <a href="../../../g/r/i/User%7EGrinBot_48c7.html" title="User:GrinBot">GrinBot</a>, Dr.Kane, <a href="../../../n/e/t/User%7ENetkinetic_8528.html" title="User:Netkinetic">Netkinetic</a>, <a href="../../../m/a/r/User%7EMarcoTolo_8040.html" title="User:MarcoTolo">MarcoTolo</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, Dhoopes, <a href="../../../t/a/k/User%7ETakometer_3fe6.html" title="User:Takometer">Takometer</a>, <a href="../../../c/m/d/User%7ECmdrObot_0605.html" title="User:CmdrObot">CmdrObot</a>, <a href="../../../m/a/g/User%7EMagnus_Manske_14b5.html" title="User:Magnus Manske">Magnus Manske</a>, <a href="../../../j/v/i/User%7EJVinocur_2f40.html" title="User:JVinocur">JVinocur</a>, <a href="../../../g/r/i/User%7EGrillo7_b07c.html" title="User:Grillo7">Grillo7</a>, <a href="../../../b/u/n/User%7EBunchofgrapes_bfbc.html" title="User:Bunchofgrapes">Bunchofgrapes</a>, <a href="../../../s/n/o/User%7ESnowmanradio_64ad.html" title="User:Snowmanradio">Snowmanradio</a>, Nitwitpicker, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, Hx, <a href="../../../o/h/n/User%7EOhnoitsjamie_fc14.html" title="User:Ohnoitsjamie">Ohnoitsjamie</a>, <a href="../../../r/e/x/User%7ERexNL_e4e0.html" title="User:RexNL">RexNL</a>, <a href="../../../8/4/7/User%7E8472.html" title="User:8472">8472</a>, <a href="../../../s/p/a/User%7ESpaully_efd5.html" title="User:Spaully">Spaully</a>, Sandy24, Anoopsinha, <a href="../../../k/u/n/User%7EKungfuadam_b5d5.html" title="User:Kungfuadam">Kungfuadam</a>, <a href="../../../i/n/g/User%7EInge-Lyubov_632e.html" title="User:Inge-Lyubov">Inge-Lyubov</a>, <a href="../../../g/-/b/User%7EG-Bot_89cf.html" title="User:G-Bot">G-Bot</a>, <a href="../../../v/i/n/User%7EVina-iwbot_07b6.html" title="User:Vina-iwbot">Vina-iwbot</a>, Cotarded, <a href="../../../b/o/t/User%7EBota47_16c2.html" title="User:Bota47">Bota47</a>, <a href="../../../s/c/h/User%7ESchzmo_9c23.html" title="User:Schzmo">Schzmo</a>, <a href="../../../r/o/y/User%7ERoyboycrashfan_c289.html" title="User:Royboycrashfan">Royboycrashfan</a>, <a href="../../../t/y/c/User%7ETycho_b338.html" title="User:Tycho">Tycho</a>, Bio-pilot, KerryB, <a href="../../../s/n/e/User%7ESnek01_6818.html" title="User:Snek01">Snek01</a>, Jsuchit, <a href="../../../h/a/l/User%7EHalibutt_9a46.html" title="User:Halibutt">Halibutt</a>, <a href="../../../d/i/b/User%7EDiberri_3d04.html" title="User:Diberri">Diberri</a>, <a href="../../../m/a/n/User%7EMani1_e14b.html" title="User:Mani1">Mani1</a>, <a href="../../../j/o/k/User%7EJOK_fc6d.html" title="User:JOK">JOK</a>, <a href="../../../i/c/e/User%7EIcelight_76ef.html" title="User:Icelight">Icelight</a>, <a href="../../../m/c/d/User%7EMcDogm_375a.html" title="User:McDogm">McDogm</a>, <a href="../../../g/l/e/User%7EGlenn_a98b.html" title="User:Glenn">Glenn</a>, <a href="../../../m/7/b/User%7EM7bot_7d8a.html" title="User:M7bot">M7bot</a>, <a href="../../../s/a/l/User%7ESalsb_a85c.html" title="User:Salsb">Salsb</a>, <a href="../../../n/a/t/User%7ENatalinasmpf_1971.html" title="User:Natalinasmpf">Natalinasmpf</a>, <a href="../../../s/a/m/User%7ESam_Korn_fe1c.html" title="User:Sam Korn">Sam Korn</a>, <a href="../../../b/a/b/User%7EBabajobu_ed0d.html" title="User:Babajobu">Babajobu</a>, <a href="../../../e/l/e/User%7EEleassar777_7cf2.html" title="User:Eleassar777">Eleassar777</a>, <a href="../../../v/i/e/User%7EVietbio_32de.html" title="User:Vietbio">Vietbio</a>, <a href="../../../e/n/s/User%7EEnSamulili_2ac9.html" title="User:EnSamulili">EnSamulili</a>, <a href="../../../t/a/k/User%7ETaka_cf5d.html" title="User:Taka">Taka</a>, Drn.sharathchandra, <a href="../../../s/t/e/User%7EStemonitis_ca3d.html" title="User:Stemonitis">Stemonitis</a>, <a href="../../../m/a/r/User%7EMargosbot_a231.html" title="User:Margosbot">Margosbot</a>, <a href="../../../c/e/y/User%7ECeyockey_fb55.html" title="User:Ceyockey">Ceyockey</a>, <a href="../../../j/n/e/User%7EJnestorius_2da6.html" title="User:Jnestorius">Jnestorius</a>, <a href="../../../m/x/p/User%7EMxpule_62f2.html" title="User:Mxpule">Mxpule</a>, <a href="../../../r/e/n/User%7ERenato_Caniatti_ecef.html" title="User:Renato Caniatti">Renato Caniatti</a>, <a href="../../../b/o/o/User%7EBoothy443_59af.html" title="User:Boothy443">Boothy443</a>, <a href="../../../t/e/n/User%7ETenOfAllTrades_d5ed.html" title="User:TenOfAllTrades">TenOfAllTrades</a>, <a href="../../../r/d/s/User%7ERdsmith4_389f.html" title="User:Rdsmith4">Rdsmith4</a>, Duffman, <a href="../../../l/e/x/User%7ELexor_1be7.html" title="User:Lexor">Lexor</a>, <a href="../../../m/l/e/User%7EMlessard_b514.html" title="User:Mlessard">Mlessard</a>, Zhuuu, <a href="../../../m/i/c/User%7EMichaelJanich_54fd.html" title="User:MichaelJanich">MichaelJanich</a>, <a href="../../../s/a/y/User%7ESayeth_39df.html" title="User:Sayeth">Sayeth</a>, <a href="../../../r/o/b/User%7ERobbot_3bd9.html" title="User:Robbot">Robbot</a>, <a href="../../../q/t/n/User%7EQtnguyen92683_6d7f.html" title="User:Qtnguyen92683">Qtnguyen92683</a>, <a href="../../../g/b/l/User%7EGbleem_11fe.html" title="User:Gbleem">Gbleem</a>, <a href="../../../a/d/a/User%7EAdamRetchless_d1d6.html" title="User:AdamRetchless">AdamRetchless</a>, <a href="../../../y/o/h/User%7EYohan_d1cf.html" title="User:Yohan">Yohan</a>, <a href="../../../j/e/n/User%7EJengod_485b.html" title="User:Jengod">Jengod</a>, <a href="../../../j/i/m/User%7EJimfbleak_6698.html" title="User:Jimfbleak">Jimfbleak</a>, <a href="../../../w/i/k/User%7EWikibot_9002.html" title="User:Wikibot">Wikibot</a>, <a href="../../../y/o/u/User%7EYoussefsan_7b7e.html" title="User:Youssefsan">Youssefsan</a>, <a href="../../../s/o/m/User%7ESomeone_else_bc03.html" title="User:Someone else">Someone else</a>, <a href="../../../m/a/v/User%7EMaveric149_24ee.html" title="User:Maveric149">Maveric149</a> and <a href="../../../l/c/_/User%7ELC_0e98.html" title="User:LC">LC</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
